{"taxa": [{"scientific_name": "nigella sativa l", "compounds": ["longifolene", "nigellidine", "dihydrofarnesyl acetate", "2,4,(10)-thujadiene", "\u03b2-caryophyllene", "\u03b1-longipinene", "cis-thujopsene", "trans-cinnamic acid", "citronellyl acetate", "trans-anethole", "bornyl acetate", "cis-pinocarveol", "\u03b3-himachalene", "terpinen-4-ol", "\u03b1-curcumene", "nigellamine a5", "\u03b1-phellandrene", "apigenin", "(e)-cinnamaldehyde", "cis-sabinene hydrate", "iso-longifolene", "dihydrocarvone", "p-cymene-8-ol", "epicatechin", "1-ethyl-2,3-dimethyl benzene", "lauric acid", "neryl acetate", "6-methyl-\u03b1-(e)-ionone", "terpinolene", "\u03b1-terpinene", "1,8-cineole", "(z,e)-farnesyl acetate", "geranyl acetone", "stigmasterol", "pentyl hexadec-12-enoate", "geranial", "rosmarinic acid", "fenchone", "\u03b1-longicyclene", "nerol", "chrysin", "2-undecanone", "\u03b1-hederin", "\u03b4-cadinene", "ocimenone (e)", "cholesterol", "\u03b1-longifolene", "benzaldehyde", "trans-carveol", "trans-\u03b1-bergamotene", "chlorogenic acid", "flavone", "umbellulone", "caffeic acid", "aromadendrene", "pinocarvone", "linoleic acid", "nigellamine a3", "myrtenol", "davanone", "1,5,8-p-menthatriene", "nigellamine b2", "trans-\u03b2-terpineol", "\u03b4-7-stigmasterol", "4-terpineol", "oleic acid", "nigellamine c", "cuminaldehyde", "\u03b4-7-avenasterol", "limonene", "p-coumaric acid", "sabinene", "\u03b2-pinene oxide", "amentoflavone", "\u03b1-zingiberene", "campesterol", "protocatechuic acid", "dl-arabinose", "thymohydroquinone dimethylether", "\u03b1-terpineol", "pentyl pentadec-11-enoate", "p-cymene", "nigellamine a2", "myristic acid", "p-cymen-7-ol", "dodecanal", "p-cymenene", "butyric acid hexadecyl ester", "5-hydroxybenzoic acid", "\u03b1-humulene", "\u03b3-terpinene", "catechin hydrated", "d-limonene", "nigellimine", "\u03b2-elemene", "salicylic acid", "\u03b1-copaene", "gallic acid", "eugenol", "\u03b3-elemene", "myricetin", "trans-piperitol", "\u03b2-bisabolol", "thymol", "quercetine", "thymohydroquinone", "n-tetradecane", "sinapinic acid", "cis-piperitol", "nigellamine a1", "trans-dihydrocarvone", "tetradecanal", "iso-longifolol", "vanillic acid", "ferulic acid", "nigellamine b1", "3-hydroxybenzoic acid", "linalool", "cis-carveol", "myristicin", "methyl linoleate", "methyl eugenol", "(z)-caryophyllene", "nigellidine-4-o-sulfite", "apiole", "dithymoquinone", "thymoquinone", "camphor", "naringenin", "p-dihydroxybenzoic acid", "trans-sabinene hydrate", "anisaldehyde", "cis-carvyl acetate", "estragole", "carvone", "\u03b1-pinene", "\u03b2-pinene", "pinocembrin", "coumarin", "palmitic acid", "nigellicine", "4,5-epoxy-1-isopropyl-4-methyl-1-cyclohexene", "linolenic acid", "methyl geranate", "\u03b1-himachalene", "\u03b2-farnesene", "trans-sabinene hydrate acetate", "(z)-isoeugenol acetate", "tricyclene", "pimaradiene", "syringic acid", "myrcene", "citronellyl n-butyrate", "kaempferol", "4-hydroxybenzoic acid", "(e,e)-farnesyl acetate", "cyclosativene", "eicosadienoic acid", "galangin", "iso-dihydrocarveol", "3-methyl nonane", "stearic acid", "n-decane", "1-methyl-3-propyl benzene", "n-nonane", "nigellamine a4", "\u03b2-bisabolene", "carvacrol", "trans-2-hydroxycinnamic acid", "n-decanoic acid", "\u03b1-ionone", "methylnonadeca-15,17-dienoate", "n-hexadecane", "thymohydroquinone methyl ether", "\u03b2-sitosterol", "borneol", "camphene", "\u03b1-thujene"], "accepted_name": "Nigella sativa", "accepted_species": "Nigella sativa", "accepted_genus": "Nigella", "inchi_keys": {"longifolene": "PDSNLYSELAIEBU-GUIRCDHDSA-N", "nigellidine": "HJKNBAAMIKPHJF-UHFFFAOYSA-N", "\u03b2-caryophyllene": "NPNUFJAVOOONJE-GFUGXAQUSA-N", "cis-thujopsene": "WXQGPFZDVCRBME-QEJZJMRPSA-N", "trans-cinnamic acid": "WBYWAXJHAXSJNI-VOTSOKGWSA-N", "citronellyl acetate": "JOZKFWLRHCDGJA-UHFFFAOYSA-N", "trans-anethole": "RUVINXPYWBROJD-ONEGZZNKSA-N", "bornyl acetate": "KGEKLUUHTZCSIP-HOSYDEDBSA-N", "\u03b3-himachalene": "PUWNTRHCKNHSAT-UHFFFAOYSA-N", "terpinen-4-ol": "WRYLYDPHFGVWKC-UHFFFAOYSA-N", "\u03b1-curcumene": "VMYXUZSZMNBRCN-UHFFFAOYSA-N", "\u03b1-phellandrene": "OGLDWXZKYODSOB-UHFFFAOYSA-N", "apigenin": "KZNIFHPLKGYRTM-UHFFFAOYSA-N", "(e)-cinnamaldehyde": "KJPRLNWUNMBNBZ-QPJJXVBHSA-N", "cis-sabinene hydrate": "KXSDPILWMGFJMM-GUBZILKMSA-N", "iso-longifolene": "CQUAYTJDLQBXCQ-NHYWBVRUSA-N", "dihydrocarvone": "AZOCECCLWFDTAP-UHFFFAOYSA-N", "p-cymene-8-ol": "XLPDVYGDNRIQFV-UHFFFAOYSA-N", "epicatechin": "PFTAWBLQPZVEMU-UKRRQHHQSA-N", "1-ethyl-2,3-dimethyl benzene": "QUBBAXISAHIDNM-UHFFFAOYSA-N", "lauric acid": "POULHZVOKOAJMA-UHFFFAOYSA-N", "neryl acetate": "HIGQPQRQIQDZMP-FLIBITNWSA-N", "terpinolene": "MOYAFQVGZZPNRA-UHFFFAOYSA-N", "\u03b1-terpinene": "YHQGMYUVUMAZJR-UHFFFAOYSA-N", "1,8-cineole": "WEEGYLXZBRQIMU-UHFFFAOYSA-N", "(z,e)-farnesyl acetate": "ZGIGZINMAOQWLX-HDVIWIBHSA-N", "geranyl acetone": "HNZUNIKWNYHEJJ-FMIVXFBMSA-N", "stigmasterol": "HCXVJBMSMIARIN-PHZDYDNGSA-N", "pentyl hexadec-12-enoate": "IGGCZPGKDZKTPZ-UHFFFAOYSA-N", "geranial": "WTEVQBCEXWBHNA-JXMROGBWSA-N", "rosmarinic acid": "DOUMFZQKYFQNTF-WUTVXBCWSA-N", "fenchone": "LHXDLQBQYFFVNW-UHFFFAOYSA-N", "nerol": "GLZPCOQZEFWAFX-YFHOEESVSA-N", "chrysin": "RTIXKCRFFJGDFG-UHFFFAOYSA-N", "2-undecanone": "KYWIYKKSMDLRDC-UHFFFAOYSA-N", "\u03b1-hederin": "KEOITPILCOILGM-LLJOFIFVSA-N", "\u03b4-cadinene": "FUCYIEXQVQJBKY-ZFWWWQNUSA-N", "cholesterol": "HVYWMOMLDIMFJA-DPAQBDIFSA-N", "\u03b1-longifolene": "PDSNLYSELAIEBU-GUIRCDHDSA-N", "benzaldehyde": "HUMNYLRZRPPJDN-UHFFFAOYSA-N", "trans-carveol": "BAVONGHXFVOKBV-ZJUUUORDSA-N", "trans-\u03b1-bergamotene": "YMBFCQPIMVLNIU-SOUVJXGZSA-N", "chlorogenic acid": "CWVRJTMFETXNAD-JUHZACGLSA-N", "flavone": "VHBFFQKBGNRLFZ-UHFFFAOYSA-N", "umbellulone": "LTTVJAQLCIHAFV-UHFFFAOYSA-N", "caffeic acid": "QAIPRVGONGVQAS-DUXPYHPUSA-N", "aromadendrene": "ITYNGVSTWVVPIC-XVIXHAIJSA-N", "pinocarvone": "TZDMGBLPGZXHJI-UHFFFAOYSA-N", "linoleic acid": "OYHQOLUKZRVURQ-HZJYTTRNSA-N", "myrtenol": "RXBQNMWIQKOSCS-UHFFFAOYSA-N", "davanone": "FJKKZNIYYVEYOL-UHFFFAOYSA-N", "1,5,8-p-menthatriene": "NJLNIOKPXKKALD-UHFFFAOYSA-N", "trans-\u03b2-terpineol": "RUJPNZNXGCHGID-UHFFFAOYSA-N", "\u03b4-7-stigmasterol": "OQMZNAMGEHIHNN-CIFIHVIMSA-N", "4-terpineol": "WRYLYDPHFGVWKC-UHFFFAOYSA-N", "oleic acid": "ZQPPMHVWECSIRJ-KTKRTIGZSA-N", "cuminaldehyde": "WTWBUQJHJGUZCY-UHFFFAOYSA-N", "\u03b4-7-avenasterol": "MCWVPSBQQXUCTB-CVRIKDQZSA-N", "limonene": "XMGQYMWWDOXHJM-UHFFFAOYSA-N", "p-coumaric acid": "NGSWKAQJJWESNS-ZZXKWVIFSA-N", "sabinene": "NDVASEGYNIMXJL-UHFFFAOYSA-N", "\u03b2-pinene oxide": "OUXAABAEPHHZPC-UHFFFAOYSA-N", "amentoflavone": "YUSWMAULDXZHPY-UHFFFAOYSA-N", "\u03b1-zingiberene": "KKOXKGNSUHTUBV-CABCVRRESA-N", "campesterol": "SGNBVLSWZMBQTH-PODYLUTMSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "dl-arabinose": "PYMYPHUHKUWMLA-UHFFFAOYSA-N", "thymohydroquinone dimethylether": "VBOKLYBFDDVUCS-UHFFFAOYSA-N", "\u03b1-terpineol": "WUOACPNHFRMFPN-UHFFFAOYSA-N", "pentyl pentadec-11-enoate": "OCNJRUIKKDPVLN-FPLPWBNLSA-N", "p-cymene": "HFPZCAJZSCWRBC-UHFFFAOYSA-N", "myristic acid": "TUNFSRHWOTWDNC-UHFFFAOYSA-N", "p-cymen-7-ol": "OIGWAXDAPKFNCQ-UHFFFAOYSA-N", "dodecanal": "HFJRKMMYBMWEAD-UHFFFAOYSA-N", "p-cymenene": "MMSLOZQEMPDGPI-UHFFFAOYSA-N", "butyric acid hexadecyl ester": "NJVKAQGGBANCKG-UHFFFAOYSA-N", "5-hydroxybenzoic acid": "IJFXRHURBJZNAO-UHFFFAOYSA-N", "\u03b1-humulene": "FAMPSKZZVDUYOS-HRGUGZIWSA-N", "\u03b3-terpinene": "YKFLAYDHMOASIY-UHFFFAOYSA-N", "d-limonene": "XMGQYMWWDOXHJM-JTQLQIEISA-N", "nigellimine": "VBMZFACBWDZUSM-UHFFFAOYSA-N", "\u03b2-elemene": "OPFTUNCRGUEPRZ-QLFBSQMISA-N", "salicylic acid": "YGSDEFSMJLZEOE-UHFFFAOYSA-N", "\u03b1-copaene": "VLXDPFLIRFYIME-XIQJJJERSA-N", "gallic acid": "LNTHITQWFMADLM-UHFFFAOYSA-N", "eugenol": "RRAFCDWBNXTKKO-UHFFFAOYSA-N", "\u03b3-elemene": "BQSLMQNYHVFRDT-CABCVRRESA-N", "myricetin": "IKMDFBPHZNJCSN-UHFFFAOYSA-N", "trans-piperitol": "HPOHAUWWDDPHRS-ZJUUUORDSA-N", "\u03b2-bisabolol": "WTVHAMTYZJGJLJ-LSDHHAIUSA-N", "thymol": "MGSRCZKZVOBKFT-UHFFFAOYSA-N", "quercetine": "REFJWTPEDVJJIY-UHFFFAOYSA-N", "thymohydroquinone": "OQIOHYHRGZNZCW-UHFFFAOYSA-N", "n-tetradecane": "BGHCVCJVXZWKCC-UHFFFAOYSA-N", "sinapinic acid": "PCMORTLOPMLEFB-ARJAWSKDSA-N", "cis-piperitol": "HPOHAUWWDDPHRS-UWVGGRQHSA-N", "trans-dihydrocarvone": "GCRTVIUGJCJVDD-IUCAKERBSA-N", "tetradecanal": "UHUFTBALEZWWIH-UHFFFAOYSA-N", "vanillic acid": "WKOLLVMJNQIZCI-UHFFFAOYSA-N", "3-hydroxybenzoic acid": "IJFXRHURBJZNAO-UHFFFAOYSA-N", "linalool": "CDOSHBSSFJOMGT-UHFFFAOYSA-N", "cis-carveol": "BAVONGHXFVOKBV-NXEZZACHSA-N", "myristicin": "BNWJOHGLIBDBOB-UHFFFAOYSA-N", "methyl linoleate": "WTTJVINHCBCLGX-NQLNTKRDSA-N", "methyl eugenol": "ZYEMGPIYFIJGTP-UHFFFAOYSA-N", "(z)-caryophyllene": "NPNUFJAVOOONJE-BLOBHPOZSA-N", "nigellidine-4-o-sulfite": "PIIGHYPMPPFOCX-UHFFFAOYSA-O", "apiole": "QQRSPHJOOXUALR-UHFFFAOYSA-N", "dithymoquinone": "FPRGRROJPRIHJP-UHFFFAOYSA-N", "thymoquinone": "KEQHJBNSCLWCAE-UHFFFAOYSA-N", "camphor": "DSSYKIVIOFKYAU-UHFFFAOYSA-N", "naringenin": "FTVWIRXFELQLPI-ZDUSSCGKSA-N", "p-dihydroxybenzoic acid": "JUHCRMVGMSHJSY-UHFFFAOYSA-N", "trans-sabinene hydrate": "KXSDPILWMGFJMM-CBMCFHRWSA-N", "anisaldehyde": "ZRSNZINYAWTAHE-UHFFFAOYSA-N", "cis-carvyl acetate": "YTHRBOFHFYZBRJ-VXGBXAGGSA-N", "estragole": "ZFMSMUAANRJZFM-UHFFFAOYSA-N", "carvone": "ULDHMXUKGWMISQ-UHFFFAOYSA-N", "\u03b1-pinene": "GRWFGVWFFZKLTI-UHFFFAOYSA-N", "\u03b2-pinene": "WTARULDDTDQWMU-UHFFFAOYSA-N", "pinocembrin": "URFCJEUYXNAHFI-ZDUSSCGKSA-N", "coumarin": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N", "palmitic acid": "IPCSVZSSVZVIGE-UHFFFAOYSA-N", "nigellicine": "FEJTUHSIRAJLOJ-UHFFFAOYSA-N", "4,5-epoxy-1-isopropyl-4-methyl-1-cyclohexene": "JVQQTQFGLBPBSV-UHFFFAOYSA-N", "linolenic acid": "DTOSIQBPPRVQHS-PDBXOOCHSA-N", "methyl geranate": "ACOBBFVLNKYODD-CSKARUKUSA-N", "\u03b1-himachalene": "ZJSIKVDEOWWVEH-UHFFFAOYSA-N", "\u03b2-farnesene": "JSNRRGGBADWTMC-NTCAYCPXSA-N", "trans-sabinene hydrate acetate": "MYCFGFMJUUNKBN-RAMGSTBQSA-N", "(z)-isoeugenol acetate": "BQEJGEKBRHVBKA-LNKPDPKZSA-N", "tricyclene": "RRBYUSWBLVXTQN-UHFFFAOYSA-N", "pimaradiene": "XDSYKASBVOZOAG-RAUXBKROSA-N", "syringic acid": "JMSVCTWVEWCHDZ-UHFFFAOYSA-N", "myrcene": "UAHWPYUMFXYFJY-UHFFFAOYSA-N", "citronellyl n-butyrate": "XQPZQXTWYZAXAK-UHFFFAOYSA-N", "kaempferol": "IYRMWMYZSQPJKC-UHFFFAOYSA-N", "4-hydroxybenzoic acid": "FJKROLUGYXJWQN-UHFFFAOYSA-N", "(e,e)-farnesyl acetate": "ZGIGZINMAOQWLX-NCZFFCEISA-N", "cyclosativene": "XBWACJDEQIZTPR-UHFFFAOYSA-N", "eicosadienoic acid": "XSXIVVZCUAHUJO-HZJYTTRNSA-N", "galangin": "VCCRNZQBSJXYJD-UHFFFAOYSA-N", "3-methyl nonane": "PLZDDPSCZHRBOY-UHFFFAOYSA-N", "stearic acid": "QIQXTHQIDYTFRH-UHFFFAOYSA-N", "n-decane": "DIOQZVSQGTUSAI-UHFFFAOYSA-N", "1-methyl-3-propyl benzene": "QUEBYVKXYIKVSO-UHFFFAOYSA-N", "n-nonane": "BKIMMITUMNQMOS-UHFFFAOYSA-N", "\u03b2-bisabolene": "XZRVRYFILCSYSP-OAHLLOKOSA-N", "carvacrol": "RECUKUPTGUEGMW-UHFFFAOYSA-N", "trans-2-hydroxycinnamic acid": "PMOWTIHVNWZYFI-AATRIKPKSA-N", "n-decanoic acid": "GHVNFZFCNZKVNT-UHFFFAOYSA-N", "\u03b1-ionone": "UZFLPKAIBPNNCA-BQYQJAHWSA-N", "methylnonadeca-15,17-dienoate": "BDWYJHVGEIPXSA-UHFFFAOYSA-N", "n-hexadecane": "DCAYPVUWAIABOU-UHFFFAOYSA-N", "thymohydroquinone methyl ether": "VBOKLYBFDDVUCS-UHFFFAOYSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "borneol": "DTGKSKDOIYIVQL-UHFFFAOYSA-N", "camphene": "CRPUJAZIXJMDBK-UHFFFAOYSA-N", "\u03b1-thujene": "KQAZVFVOEIRWHN-UHFFFAOYSA-N"}, "inchi_key_simps": {"longifolene": "PDSNLYSELAIEBU", "nigellidine": "HJKNBAAMIKPHJF", "\u03b2-caryophyllene": "NPNUFJAVOOONJE", "cis-thujopsene": "WXQGPFZDVCRBME", "trans-cinnamic acid": "WBYWAXJHAXSJNI", "citronellyl acetate": "JOZKFWLRHCDGJA", "trans-anethole": "RUVINXPYWBROJD", "bornyl acetate": "KGEKLUUHTZCSIP", "\u03b3-himachalene": "PUWNTRHCKNHSAT", "terpinen-4-ol": "WRYLYDPHFGVWKC", "\u03b1-curcumene": "VMYXUZSZMNBRCN", "\u03b1-phellandrene": "OGLDWXZKYODSOB", "apigenin": "KZNIFHPLKGYRTM", "(e)-cinnamaldehyde": "KJPRLNWUNMBNBZ", "cis-sabinene hydrate": "KXSDPILWMGFJMM", "iso-longifolene": "CQUAYTJDLQBXCQ", "dihydrocarvone": "AZOCECCLWFDTAP", "p-cymene-8-ol": "XLPDVYGDNRIQFV", "epicatechin": "PFTAWBLQPZVEMU", "1-ethyl-2,3-dimethyl benzene": "QUBBAXISAHIDNM", "lauric acid": "POULHZVOKOAJMA", "neryl acetate": "HIGQPQRQIQDZMP", "terpinolene": "MOYAFQVGZZPNRA", "\u03b1-terpinene": "YHQGMYUVUMAZJR", "1,8-cineole": "WEEGYLXZBRQIMU", "(z,e)-farnesyl acetate": "ZGIGZINMAOQWLX", "geranyl acetone": "HNZUNIKWNYHEJJ", "stigmasterol": "HCXVJBMSMIARIN", "pentyl hexadec-12-enoate": "IGGCZPGKDZKTPZ", "geranial": "WTEVQBCEXWBHNA", "rosmarinic acid": "DOUMFZQKYFQNTF", "fenchone": "LHXDLQBQYFFVNW", "nerol": "GLZPCOQZEFWAFX", "chrysin": "RTIXKCRFFJGDFG", "2-undecanone": "KYWIYKKSMDLRDC", "\u03b1-hederin": "KEOITPILCOILGM", "\u03b4-cadinene": "FUCYIEXQVQJBKY", "cholesterol": "HVYWMOMLDIMFJA", "\u03b1-longifolene": "PDSNLYSELAIEBU", "benzaldehyde": "HUMNYLRZRPPJDN", "trans-carveol": "BAVONGHXFVOKBV", "trans-\u03b1-bergamotene": "YMBFCQPIMVLNIU", "chlorogenic acid": "CWVRJTMFETXNAD", "flavone": "VHBFFQKBGNRLFZ", "umbellulone": "LTTVJAQLCIHAFV", "caffeic acid": "QAIPRVGONGVQAS", "aromadendrene": "ITYNGVSTWVVPIC", "pinocarvone": "TZDMGBLPGZXHJI", "linoleic acid": "OYHQOLUKZRVURQ", "myrtenol": "RXBQNMWIQKOSCS", "davanone": "FJKKZNIYYVEYOL", "1,5,8-p-menthatriene": "NJLNIOKPXKKALD", "trans-\u03b2-terpineol": "RUJPNZNXGCHGID", "\u03b4-7-stigmasterol": "OQMZNAMGEHIHNN", "4-terpineol": "WRYLYDPHFGVWKC", "oleic acid": "ZQPPMHVWECSIRJ", "cuminaldehyde": "WTWBUQJHJGUZCY", "\u03b4-7-avenasterol": "MCWVPSBQQXUCTB", "limonene": "XMGQYMWWDOXHJM", "p-coumaric acid": "NGSWKAQJJWESNS", "sabinene": "NDVASEGYNIMXJL", "\u03b2-pinene oxide": "OUXAABAEPHHZPC", "amentoflavone": "YUSWMAULDXZHPY", "\u03b1-zingiberene": "KKOXKGNSUHTUBV", "campesterol": "SGNBVLSWZMBQTH", "protocatechuic acid": "YQUVCSBJEUQKSH", "dl-arabinose": "PYMYPHUHKUWMLA", "thymohydroquinone dimethylether": "VBOKLYBFDDVUCS", "\u03b1-terpineol": "WUOACPNHFRMFPN", "pentyl pentadec-11-enoate": "OCNJRUIKKDPVLN", "p-cymene": "HFPZCAJZSCWRBC", "myristic acid": "TUNFSRHWOTWDNC", "p-cymen-7-ol": "OIGWAXDAPKFNCQ", "dodecanal": "HFJRKMMYBMWEAD", "p-cymenene": "MMSLOZQEMPDGPI", "butyric acid hexadecyl ester": "NJVKAQGGBANCKG", "5-hydroxybenzoic acid": "IJFXRHURBJZNAO", "\u03b1-humulene": "FAMPSKZZVDUYOS", "\u03b3-terpinene": "YKFLAYDHMOASIY", "d-limonene": "XMGQYMWWDOXHJM", "nigellimine": "VBMZFACBWDZUSM", "\u03b2-elemene": "OPFTUNCRGUEPRZ", "salicylic acid": "YGSDEFSMJLZEOE", "\u03b1-copaene": "VLXDPFLIRFYIME", "gallic acid": "LNTHITQWFMADLM", "eugenol": "RRAFCDWBNXTKKO", "\u03b3-elemene": "BQSLMQNYHVFRDT", "myricetin": "IKMDFBPHZNJCSN", "trans-piperitol": "HPOHAUWWDDPHRS", "\u03b2-bisabolol": "WTVHAMTYZJGJLJ", "thymol": "MGSRCZKZVOBKFT", "quercetine": "REFJWTPEDVJJIY", "thymohydroquinone": "OQIOHYHRGZNZCW", "n-tetradecane": "BGHCVCJVXZWKCC", "sinapinic acid": "PCMORTLOPMLEFB", "cis-piperitol": "HPOHAUWWDDPHRS", "trans-dihydrocarvone": "GCRTVIUGJCJVDD", "tetradecanal": "UHUFTBALEZWWIH", "vanillic acid": "WKOLLVMJNQIZCI", "3-hydroxybenzoic acid": "IJFXRHURBJZNAO", "linalool": "CDOSHBSSFJOMGT", "cis-carveol": "BAVONGHXFVOKBV", "myristicin": "BNWJOHGLIBDBOB", "methyl linoleate": "WTTJVINHCBCLGX", "methyl eugenol": "ZYEMGPIYFIJGTP", "(z)-caryophyllene": "NPNUFJAVOOONJE", "nigellidine-4-o-sulfite": "PIIGHYPMPPFOCX", "apiole": "QQRSPHJOOXUALR", "dithymoquinone": "FPRGRROJPRIHJP", "thymoquinone": "KEQHJBNSCLWCAE", "camphor": "DSSYKIVIOFKYAU", "naringenin": "FTVWIRXFELQLPI", "p-dihydroxybenzoic acid": "JUHCRMVGMSHJSY", "trans-sabinene hydrate": "KXSDPILWMGFJMM", "anisaldehyde": "ZRSNZINYAWTAHE", "cis-carvyl acetate": "YTHRBOFHFYZBRJ", "estragole": "ZFMSMUAANRJZFM", "carvone": "ULDHMXUKGWMISQ", "\u03b1-pinene": "GRWFGVWFFZKLTI", "\u03b2-pinene": "WTARULDDTDQWMU", "pinocembrin": "URFCJEUYXNAHFI", "coumarin": "ZYGHJZDHTFUPRJ", "palmitic acid": "IPCSVZSSVZVIGE", "nigellicine": "FEJTUHSIRAJLOJ", "4,5-epoxy-1-isopropyl-4-methyl-1-cyclohexene": "JVQQTQFGLBPBSV", "linolenic acid": "DTOSIQBPPRVQHS", "methyl geranate": "ACOBBFVLNKYODD", "\u03b1-himachalene": "ZJSIKVDEOWWVEH", "\u03b2-farnesene": "JSNRRGGBADWTMC", "trans-sabinene hydrate acetate": "MYCFGFMJUUNKBN", "(z)-isoeugenol acetate": "BQEJGEKBRHVBKA", "tricyclene": "RRBYUSWBLVXTQN", "pimaradiene": "XDSYKASBVOZOAG", "syringic acid": "JMSVCTWVEWCHDZ", "myrcene": "UAHWPYUMFXYFJY", "citronellyl n-butyrate": "XQPZQXTWYZAXAK", "kaempferol": "IYRMWMYZSQPJKC", "4-hydroxybenzoic acid": "FJKROLUGYXJWQN", "(e,e)-farnesyl acetate": "ZGIGZINMAOQWLX", "cyclosativene": "XBWACJDEQIZTPR", "eicosadienoic acid": "XSXIVVZCUAHUJO", "galangin": "VCCRNZQBSJXYJD", "3-methyl nonane": "PLZDDPSCZHRBOY", "stearic acid": "QIQXTHQIDYTFRH", "n-decane": "DIOQZVSQGTUSAI", "1-methyl-3-propyl benzene": "QUEBYVKXYIKVSO", "n-nonane": "BKIMMITUMNQMOS", "\u03b2-bisabolene": "XZRVRYFILCSYSP", "carvacrol": "RECUKUPTGUEGMW", "trans-2-hydroxycinnamic acid": "PMOWTIHVNWZYFI", "n-decanoic acid": "GHVNFZFCNZKVNT", "\u03b1-ionone": "UZFLPKAIBPNNCA", "methylnonadeca-15,17-dienoate": "BDWYJHVGEIPXSA", "n-hexadecane": "DCAYPVUWAIABOU", "thymohydroquinone methyl ether": "VBOKLYBFDDVUCS", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "borneol": "DTGKSKDOIYIVQL", "camphene": "CRPUJAZIXJMDBK", "\u03b1-thujene": "KQAZVFVOEIRWHN"}}], "text": "Biomedicine & Pharmacotherapy 143 (2021) 112182 Available online 1 October 2021 0753-3322/\u00a9 2021 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). A review of ethnobotany, phytochemistry, antimicrobial pharmacology and toxicology of Nigella sativa L. Md. Sanower Hossain a,b,*, Ashik Sharfaraz c,1, Amit Dutta c,1, Asif Ahsan c,2, Md. Anwarul Masud c,2, Idris Adewale Ahmed d, Bey Hing Goh e,f, Zannat Urbi g, Md. Moklesur Rahman Sarker h,i, Long Chiau Ming j,** a Department of Biomedical Science, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, 25200 Kuantan, Malaysia b Faculty of Science, Sristy College of Tangail, 1900 Tangail, Bangladesh c Department of Biotechnology & Genetic Engineering, Mawlana Bhashani Science and Technology University, 1902 Tangail, Bangladesh d Center for Natural Products Research and Drug Discovery, Universiti Malaya, 50603 Kuala Lumpur, Malaysia e Biofunctional Molecule Exploratory (BMEX) Research Group, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia f College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, PR China g Department of Industrial Biotechnology, Faculty of Industrial Sciences & Technology, Universiti Malaysia Pahang, 26300 Kuantan, Pahang, Malaysia h Department of Pharmacy, State University of Bangladesh, 77 Satmasjid Road, Dhanmondi, Dhaka 1205, Bangladesh i Health Med Science Research Limited, 3/1 Block F, Lalmatia, Dhaka 1207, Bangladesh j PAP Rashidah Sa\u2019adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, BE1410 Brunei, Darussalam A R T I C L E I N F O Keywords: Antibacterial agent Antibiotic resistance Bioactive molecules Medicinal plant Natural products PhytochemistryToxicology A B S T R A C T Nigella sativa L. is one of the most extensively used traditional medicinal plants. This widely studied plant is known to display diverse pharmacological actions, including antimicrobial activities. Current literature has documented its multi-target mode of antimicrobial actions. N. sativa or its bioactive compounds, such as thy- moquinone, can induce oxidative stress, cell apoptosis (by producing reactive oxygen species), increase mem- brane permeability, inhibit efflux pumps, and impose strong biocidal actions. Despite its well-documented antimicrobial efficacy in the experimental model, to the best of our knowledge its antimicrobial mechanisms highlighting the multi-targeting properties have yet to be well discussed. Is N. sativa or thymoquinone a valuable lead compound for therapeutic development for infectious diseases? Are N. sativa\u2019s bioactive compounds po- tential antimicrobial agents or able to overcome antimicrobial resistance? This review aims to discuss the antimicrobial pharmacology of N. sativa-based treatments. Additionally, it provides a holistic overview of the ethnobotany, ethnopharmacology, and phytochemistry of N. sativa. 1. Introduction Infectious diseases (IDs) are among the top ten deadly diseases globally, and the menace of growing antimicrobial resistance (AMR) has challenged and reduced the effectiveness of most clinical antibiotics [1]. Irrational use of antibiotics causes an increased rate of AMR, resulting in high AMR-related deaths globally [2]. For example, methicillin-resistant Staphylococcus aureus (MRSA) infected patients are 64% more likely to die than patients infected with drug-sensitive strains [1]. Additionally, host susceptibility changes and altering the genetic makeup of micro- organisms themselves have caused a remarkable growth of AMR worldwide [3]. A multi-target drug approach could be a sustainable strategy to overcome AMR problems, because bacterial resistance to single-target antibiotics develops too rapidly to be sustainable, and resistance to new drugs often develops even before they reach the market [4]. * Corresponding author at: Department of Biomedical Science, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, 25200 Kuantan, Malaysia. ** Corresponding author. E-mail addresses: mshossainbge@gmail.com, sanower.h@live.iium.edu.my (Md.S. Hossain), urbi.zannat@gmail.com (Z. Urbi), long.ming@ubd.edu.bn (L.C. Ming). 1 Both authors contributed equally and shared the second author position 2 Both authors contributed equally and shared the third author position Contents lists available at ScienceDirect Biomedicine & Pharmacotherapy journal homepage: www.elsevier.com/locate/biopha https://doi.org/10.1016/j.biopha.2021.112182 Received 8 August 2021; Received in revised form 5 September 2021; Accepted 7 September 2021 Biomedicine & Pharmacotherapy 143 (2021) 112182 2 Therefore, the current drug discovery trend has changed from \u201cone-- molecule-one-target-one-disease\u201d to \u201cone molecule-multi-targets modula- tion.\u201d Naturally, plant-derived molecules possess the ability to multi-target as they fight against predators like bacteria, fungi, vi- ruses, insects, and herbivores, from their germination to maturity stages, and undergo challenging defense mechanisms for survival [5-7]. So, instead of developing new antibiotics, exploring potential antimicrobial agents from plant sources is convenient and cost-effective. Moreover, access to plant sources is easy and reliable since about 75\u201380% (more than six billion) of the world\u2019s population depends on traditional medicine-based health care, especially in the less developed and developing countries of the world [8\u201310]. Nigella sativa L. (NS) is a potent medicinal plant used since ancient times that has been investigated widely to prove its traditional claims. The seeds or extracted oil of NS are traditionally used alone or in com- bination with other products like honey, lint, melted butter, and as- tringents in Islamic medicine, ayurvedic medicine, Unani traditional medicine, and indigenous medicine. They are used for various diseases or health conditions, including abdominal disorders, abscesses, anorexia, worm infections, asthma, bronchitis, cardiovascular disease, chronic headache, colic, coryza, coughs, dermatosis, diabetes, diar- rhoea, dispiritedness, eye infections, fatigue, fever, galactopoiesis, headaches, haemorrhoids, hypertension, jaundice, liver ailments, metabolic syndrome, nasal ulcers, obesity, orchitis, pulmonosis, repro- ductive disorders, respiratory infections, rheumatism, sinusitis and sore eyes, and also as a stimulant for body energy [11\u201315]. The therapeutic effects of NS are due to its richness in several phy- tochemicals, nutritionally vital constituents, and polyunsaturated fatty acids (PUFA). NS oil is on the United States Food and Drug Adminis- tration\u2019s (FDA) \u201cGenerally Recognized as Safe\u201d list. It has multiple bioactive molecules, including thymoquinone (TQ), p-cymene, \u03b1-thu- jene, carvacrol, \u03b2-pinene, limonene, methyl linoleate, sabinene, D- limonene, 4,5-epoxy-1-isopropyl-4- methyl-1-cyclohexene, and 4- terpineol [16\u201319], of which TQ exerts many pharmacological activ- ities, including antimicrobial, anticonvulsant, anticancer, anti-histaminic, anti-diabetic, anti-inflammatory, and antioxidant [20]. It also significantly inhibits the formation of biofilm, which increases AMR in antibiotic-susceptible microorganisms [21,22]. This action probably increases the production of reactive oxygen species in bacterial cells. Antimicrobial activities of NS or its secondary metabolites have been reported. TQ and other bioactive compounds produce ROS, which prompts oxidative stress and cell apoptosis [22] or increases bacteria membrane permeability, thereby promoting the influx of antimicrobial substances [23]. Nigellidine has a binding capacity to N-terminus pro- tease and nucleocapsid, and inhibits viral growth [24]. Some other compounds, such as \u03b1-hederin and thymohydroquinone, bind to the ACE2 receptor and disrupt viral host interaction [25]. The essential oil of NS (1.5 mg/ml) inhibits the production of mycelia (67.4%) and aflatoxin in Aspergillus parasiticus and TQ generates oxidative stress in Candida glabrata [26,27]. Additionally, NS shows strong biocidal prop- erties against parasites [28]. Numerous in vitro and in vivo studies, including many clinical trials, have demonstrated the therapeutic effi- cacy of NS against IDs [20,21,27,29\u201333]. Is NS or TQ a valuable lead compound for therapeutic development for IDs? Are NS\u2019s bioactive compounds potential antimicrobial agents or able to overcome AMR? This review aims to answer these questions by considering the various contributing mechanisms to the antimicrobial pharmacology of NS-based treatment. Additionally, this review provides a holistic over- view of the ethnobotany, ethnopharmacology, and phytochemistry of NS, prior to exemplifying its antimicrobial properties and involved mechanisms. Key references are cited to illustrate the concept of mechanisms of NS\u2019s antimicrobial actions and are not meant to be comprehensive. 2. Methodology Literature was searched using electronic databases, including PubMed (http://www.ncbi.nlm.nih.gov/pubmed), ScienceDirect (http://www.sciencedirect.com/), Scopus (http://www.scopus.com/), Web of Science (https://apps.webofknowledge.com/), and advanced search in Google Scholar (http://scholar.google.com.my/), as well as recognized books, abstract, and thesis/dissertation. The following key- words are \"Nigella sativa\", \u201cBlack seed\u201d, Black cumin\u201d, \"antimicrobial\", \"anti-bacterial\", \"antiviral\", \"antifungal\", and \"anti-parasitic\" were used to search the literature. A combination of keywords was used in search engines during the literature survey from years 1951\u20132021. The relevant papers from the list of references of all retrieved available articles were also searched in the aforementioned databases mentioned above. Other relevant papers from the list of references of all available articles were also searched. All structures of chemical constituents have been drawn using ChemDraw Professional 16.0 software (PerkinElmer). The upda- ted international union of pure and applied chemistry (IUPAC) names of isolated compounds of this plant were check-in the PubChem database. 3. Nigella sativa 3.1. Origin and global distribution The origin of NS is not well documented. Most probably, NS is indigenous to the Mediterranean region [34]. As the seeds of this plant were first discovered in Tutankhamun\u2019s tomb in Egypt in the 18th dy- nasty (1549/1550\u20131292 BCE) [35], it implies that the origin of this plant is Egypt and its adjoining regions. However, NS is distributed globally and cultivated in many countries and regions of the world, including, but not limited to, the Middle Eastern Mediterranean region, Central and Southern Europe, the former Soviet Union (Baltic states, Central Asia, Eastern Europe, Russia, and Transcaucasia), Northern Af- rica, Sudan, Ethiopia, Kenya, Somalia, Djibouti, India, Pakistan, Bangladesh, Sri Lanka, Nepal, Iran, Syria, Turkey, and Saudi Arabia [36, 37]. The plant is commercially grown in many north Indian states, and India is the world\u2019s largest producer and exporter of NS [36,38]. 3.2. Taxonomic hierarchy The taxonomic serial number of N. sativa is 506592 [39]. Taxonomic Nomenclature Characteristics Kingdom Plantae Plantes, Planta, Vegetal, plants Subkingdom Viridiplantae Green plants Infrakingdom Streptophyta Land plants Superdivision Embryophyta Division Tracheophyta Vascular plants, tracheophytes Subdivision Spermatophytina Spermatophytes, seed plants, phane\u0301rogames Class Magnoliopsida Superorder Ranunculanae Order Ranunculales Family Ranunculaceae Buttercups, boutons d\u2032or, crowfoot Genus Nigella L. Species Nigella sativa L. 3.3. Plant description NS is an erect, herbaceous flowering plant with a stiff and multi- branched stem and a well-developed taproot. The agro-morphological traits of NS are distinguishable from other herbaceous plants as well as different accessions of NS. The detailed agro-morphological traits of NS [38,40,41] are presented in Table 1. Fig. 1 shows the anatomy of NS [34]. The different body parts are also indicated clearly, including the cross and transverse sections of the fruits and seeds (Fig. 1). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 3 3.4. Vernacular names The vernacular name\u2014 in other words, local name, common name or non-Latin name\u2014of a plant or animal is derived from the common native speech of everyday life that is distinguishable from the binomial nomenclature. This name originated based on plant morphology, habit and habitat, organoleptic properties, and therapeutic uses. Generally, medicinal plants are traded with their vernacular names [42]. There- fore, knowing the vernacular names is crucial for folk-taxonomic iden- tification. At the same time, it provides information on plant morphology and gives information on habit and habitat, organoleptic properties, and therapeutic actions of the medicinal plant. However, this nomenclature does not always correspond one-to-one with scientific plant names. For example, both Drypetes afzelii and Adansonia digitate are known as Kiri to the Susu or Soso people of Guinea and Sierra Leone, West Africa [42]. Such complications are prevalent for vernacular names. NS is commonly known as \u2018black seed\u2019 in English because the seeds usually turn black upon exposure to air. It is also referred to as \u2018Alha- bahat Alsawda\u2019, \u2018Habbatus Sauda\u2019, and \u2018Alkamoun Alaswad\u2019, among the Muslim community, in reference to the colour of its seeds [43]. Other vernacular names of NS are presented in Table 2. The data were extracted from references [12,44,45]. 3.5. Agronomic techniques Conventionally, NS is propagated via seeds [46]. The growing season of this crop varies extensively depending on the geographical location of the cultivation area. It is grown as a winter crop in the tropics, whereas in temperate regions it is grown as a spring-summer or autumn crop [47]. Several studies suggested that seeds sown in early spring, with a 30 cm or 40 cm spacing and a depth of 2 cm, give a better yield [48] while the soil pH is 8.2 and rainfall is 790 mm [49]. The cultivation of NS is commonly seen in cold temperatures. However, seed dormancy is one of the significant setbacks in cultivating this plant [50]. Germination of NS seed is very low (12\u201315%), and stratification for three weeks has proven to be effective for breaking its dormancy and germination [46,48]. Furthermore, a temperature of 12\u201318 \u25e6C and 60% soil moisture are suitable for massive seed germi- nation [46]. In order to increase its grain size and oil content, one or two irrigations are recommended at the flowering and seed formation stage [45]. There is a relationship of yield with genetic varieties of the same plant species [51]. Selection of the high yield of secondary metabolite varieties of NS and production through vegetative propagation is essential. Since seedlings have genetic variations, vegetative propaga- tion, for example, adventitious rooting and plant tissue cultures [52,53], is recommended for mass-scale production. Environmental factors such as abiotic and biotic stress impact the yield of secondary metabolites [54\u201356]; these factors could also be considered for NS production. In some cases, abiotic stress, such as salinity stress, increases the yield of secondary lead compounds in plants [57], because stress conditions alter the metabolic pathway to accumulate the related metabolites to defend against adverse conditions [58,59]. NS plants manifest extreme vari- ability in phytochemical profiles due to the adverse effects of changing climatic and environmental conditions [50,60]. For this reason, in vitro seed germination as well as vegetative propagation techniques are good choices for large-scale production of this plant with regular phyto- chemical profiles under aseptic and controlled conditions. 4. Ethnopharmacological uses NS has been commonly used for medicinal and culinary purposes for many centuries [61]. Therefore, it is essential to study the ethnobotany of NS due to its wide use in the different parts of the world, from gen- eration to generation. Due to traditional knowledge and customs, different communities have developed unique practices concerning NS and its medicinal uses. 4.1. Medicinal uses Traditional medicine practices like Unani, Ayurveda [37], and the Arabian, Indian, and Chinese civilizations have used NS for a long time due to its numerous benefits [62]. For example, in Ayurveda, NS is known to balance Vata (movement energy) and Kapha (structure and lubrication energy), and increase Pitta (metabolism or digestion en- ergy). The therapeutic uses of NS seeds mentioned in the Unani system include stomachic, laxative, carminative and galactagogue, and to counter inflammation, ascites, jaundice, piles, tertian fever, paralysis, and eye diseases. It is also used to combat headaches, cough and asthma, and to expel kidney stones. 4.2. Culinary and other traditional uses NS seeds have a pungent, bitter taste and aroma. They are used as a condiment in curries in many cultures. NS is used as a flavouring addi- tive in bread and pickles, and is also added to tea, coffee, casseroles etc. The grounded NS seeds are usually sprinkled on salads or mixed with honey. NS is an ingredient of the spice mixture panch phoron, and the dry-roasted seeds are sometimes used to flavour curries, pulses, and vegetables [37,63]. NS seeds have also been used as a liver tonic, diaphoretic, diuretic, stomachic, emmenagogue, and control for parasitic infections [37,64]. NS can be combined with other ingredients to cure diarrhoea, dyspepsia, reflux, obesity and dyspnea, and to freshen breath. The seeds are taken with buttermilk to treat persistent hiccups and treat anorexia, vomiting, oedema, and puerperal diseases [63,64]. They are useful against mer- cury poisoning, leprosy, flatulence, and polio [61,63], and can treat amenorrhea, dysmenorrhea, and skin eruptions. A tincture prepared from NS seeds has been proven to be useful [62]. It is also used as a vermifuge, and its oil extract is taken orally as a daily tonic due to its immunostimulant property [31,61]. Many people use the oil to treat skin conditions, including eczema, Table 1 Agro-morphological traits of Nigella sativa. Trait Value/characteristics Plant height 30\u201370 cm Stem Diameter 0.65\u20130.98 cm Shape Angular Leaves Arrangement Alternate Length 2.5\u20135.0 cm Width 2.0\u20132.5 cm Shape Linear to lanceolate Phyllotaxis 1\u20132 Pinna/rachis 5\u20136 Root Length 12.74 \u2013 15.08 cm Flower Color Pink, white, yellow, pale blue, or pale purple color Size 2.74 cm \u00d7 2.78 cm Number of petals 5\u201310 Number of sepals 4\u20136 Seed Capsule size 0.4\u20131.7 cm Seed/capsule 59.29 \u00b1 3.2 Color Black Size 2.33 mm \u00b1 0.1 \u00d7 1.14 mm \u00b1 0.02 Shape Acute, angles sharp, ovate, tetrangular, more tapering at the end. Flowering and Fruiting time January to April Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 4 psoriasis, and boils. Beeswax mixed with black seed oil is also used for skin infections, burns, joint pain relief, moisturizers, or anti-wrinkle agents [62,63]. The oil also has antiseptic properties and can be applied externally. To restore a lost sense of smell, dried pods are snif- fed. They are used as insect repellents such as mothballs, and to preserve woollen fabrics from insect damage by scattering between the folds of fabrics [62]. 4.3. Documentation of uses of Nigella sativa in religious and medical scripts The names of medicinal plants, their formulation, and their impor- tance has been mentioned in religious books [65,66]. NS is mentioned in books including The Prophetic Medicine and the Bible \u2013 two significant books across the old and new testaments (Isaiah 28:25,27 and Matthew 23:23). In the Bible, NS is cited more than any other plant. It is used in cancer treatment as well as in birth control [67]. NS is the curative \u201cblack cumin\u201d in the Bible and is described as Melanthion by Hippo- crates and Dioscorides, and as Gith by Pliny [68]. Prophet Mohammed (Peace Be Upon Him) narrated that NS seed can cure every ailment or illness except death (Al-Bhukhaari, 5688). Ibn Sina, also known as Avicenna in the west, who is famous for his book \u201cThe Canon of medicine,\u201d advised about the use of NS. It helps the body recover from dispiritedness and fatigue and boosts the body\u2019s energy [69]. Pedanius Dioscorides reported using NS seeds for food and ther- apeutic purposes to treat diseases of the eyes, toothache, and leprosy, to increase urine, and to repel snakes. In Babylonia, the NS plant was used externally to treat swelling and bruises, and internally to treat stomach problems. The physician Assaf started its medical uses to treat colds in the chest, head and body, nose infections and bright skin spots, as well as to increase semen and virility, and to improve hair growth. It also served as a pharmaceutical constituent against venomous creatures\u2019 stings and poisons [61]. In the history of Islamic medicine, NS is a \u201cmiraculous or blessed\u201d plant. Muslim scholars went to tremendous lengths to explore the remedial features of this plant. Its importance is stated in \u201cProphetic Medicine\u201d tradition. Aishah (may Allah be pleased with her) narrated that she heard the messenger of Allah (Peace Be Upon Him) saying: \u201cThere is healing in black cumin for every disease, except as-saam\u201d. Ibn Fig. 1. Nigella sativa and its different body parts. 1. Habit, 2. Petal, 3. Stamen (front view), 4. Fruit, 5. Fruit (transverse section), 6. Seeds, and 7. Seeds (longitudinal and transverse section). (Artwork credit: Rabyea Jahan Mukti1). 1 Department of Computer Science and Engineering, Uttara University, Dhaka-1230, Bangladesh Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 5 Shihab said: As-saam is death [Sahih Bukhari, Volume 7, Book 71, Hadith 591; Sunan Ibn Majah, Vol. 4, Book of Medicine, Hadith 3449]. In the Hadith above, the formulation of NS is also clearly stated: \u201cTake five or seven (seeds) and grind them to a powder, then drop them into his nose with drops of olive oil, on this site and on this site\u201d for the treatment of sickness. It is stated in the books of Seerah that Nabi-e- Akram (Peace Be Upon Him) himself used to take black seed for thera- peutic purposes together with honey syrup [70,71]. NS was ascertained by Suhar Bakht and called habb-i-Sajzi, Sigzi grains. The immense benefits of NS have been described by many ancient scholars, including ancient Greek physicians like Hippocrates (460\u2013370 BCE) and Dioscorides (40\u201390 CE), Galen (129\u2013200/216 CE), Muslim scholars like Al-Biruni (973\u20131048) and Ibn Sina (980\u20131037) (Table 3). 4.4. Use of Nigella sativa in modern medicine Many of the traditional or historical uses of NS have been scientifi- cally examined. The medicinal importance and scientific quest of this plant can be understood from the findings of an advanced search in the PubMed database (as of 5 January 2021), with the cumulative publi- cation record presented in Fig. 2. A systematic search using the following keywords (Nigella sativa[Title/Abstract]) OR (black seed [Title/Abstract]) retrieved 1534 journal articles, of which 1065 were from Medline only. Further filtration revealed 1365 journal articles, of which 67 are clinical trials in the PubMed database. Among the (sys- temic) reviews, Medline covered only 97 out of 169 in PubMed. The plant has attracted more focus in recent years, as evidenced by the gradual upward trend of publications (Fig. 2). In the twentieth century, only 54 and 46 journal articles were published in the PubMed and Medline databases, respectively. This number has increased from the beginning of the twentieth century. In 2020 alone, 176 publications were included in PubMed, of which 17 articles are relevant to corona- virus disease (COVID-19). As NS has prominent antiviral compounds, such as TQ, extensive investigation is in progress, including clinical trials. It has been reported that the antiviral action of TQ is equivalent or likely superior to chloroquinone and hydroxychloroquinone. TQ demonstrated a good safety profile, whereas chloroquinone and hydroxychloroquinone showed toxicity effects [72,73]. Extant literature also provides much-needed evidence to support NS usage. For example, Bamosa, Kaatabi, Lebdaa, Elq and Al-Sultanb [74] reported that the grounded NS (supplement of 2 gm/day for three months in 94 uncontrolled types-2 diabetes mellitus patients) produced significant improvement in glycemia and diabetes control laboratory parameters. NS also showed mnemonic or nootropic properties. Among the elderly, its commercially available capsules (500 mg, taken for nine weeks) were shown to increase executive functions, as shown by various memory-related tests (letter cancellation, logical memory, trail making, digit span, and Stroop tests) [75]. Taking 500 mg NS capsules daily for four weeks as a nutritional supplement reduces anxiety, improves memory, and stabilizes mood [43]. Other clinical studies revealed that NS has activity against allergic diseases. Commercially available black seed oil capsules with the brand name Immerfit\u00ae were applied to pa- tients with allergic diseases. Each capsule contained 500 mg NS oil with 1.5 mg \u03b2- carotene, 6 mg of vitamin E, and 70 \u03bcg biotin for stabilization. All study groups were given capsules at 40\u201380 mg/kg/day. The four studies showed that NS oil effectively relieved allergic disease symptoms (atopic, allergic rhinitis, bronchial asthma, eczema) [76]. 5. Chemical compositions and phytocompounds The following section outlines and discusses the chemical composi- tion of NS, the activity of phytocompounds derived from NS, and structure\u2013activity relationship of these active molecules. 5.1. Chemical compositions NS seed contains a tiny amount of essential oils (0.4\u20131.49%), about 30\u201345% fixed oils and other compounds (Table 4). The concentration of other compounds varies. NS contains amino acids, proteins, carbohy- drates as well as bioactive molecules. The therapeutic efficacy of a plant depends on the phytocompounds Table 2 The vernacular name of Nigella sativa. Language Name Language Name Arabic Habatut Barakah Shooneez Hebrew Ketzakh Habba Sauda Indonesian Jintan hitam Habb al-barka, Kannada Krishna Jeerige Kamun eswid Malayalam Karim jerrakam Habbat al-barakah Marathi Kalonji Jire Assamese Kaljeera Persian Siah Dana Kolajeera Siya\u0302h da\u0302ne Amharic Tikur azmud Siyah daneh Bengali Kalo jeeray Portuguese Cominho-negro Bosnian \u00feurekot6 Punjabi Kalvanji Chinese Hei Zhong Cao \u9ed1\u7a2e\u8349 Russian Chernushka English Fennel flower, Black cumins Sanskrit Krishana \u2013 Jiraka Love-in-amist Upakunchika Nutmeg flower Spanish Ajenuz, Roman coriander Aran\u0303uel Black caraway or blackseed Swedish Svartkummin Black sesame Tamil Karum jeerakam French Cheveux de Ve\u0301nus Karum cheerakam Nigelle Turkish Co\u0308rek out Nigelle de Cre\u0300te Urdu Kalonji Toute e\u0301pice Mangrail German Schwarzk\u00fcmmel Kalaunji Hindi Kalonji Kalaunji Mangrail Table 3 Health benefits of Nigella sativa reported in historical medicine. Scholars Period Health benefits Pharaoh Tutankhamen 1341\u20131323 BC Epilepsy and cerebral malaria Hippocrates 460\u2013370 BC Treat diseases of women and children, such as vaginal and oral thrush and skin conditions. Dioscorides 40\u201390 AD Cure headache, toothaches, nasal congestion, intestinal worms, and promote menstruation and milk production Galen 129\u2013210 AD Hepatic and digestive disorders, common cold, and stimulants in a variety of conditions Al-Biruni 973\u20131048 Excite body\u2019s energy and recover exhaustion or dissipatedness Ibn Sina 980\u20131037 Stimulates body\u2019s energy, recover from fatigue or dispiritedness and cancer 0 100 200 300 400 500 600 700 800 900 1000 1965-2000 2001-2005 2006-2010 2011-2015 2016-2020 N u m b e r o f P u b li c a ti o n s Year Pubmed Medline Fig. 2. Nigella sativa cumulative publication trends in PubMed database (as of 5 January 2021). Medline data were extracted to differentiate the trend, which is specific for biomedical and life science research. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 6 (secondary metabolites). Phytoconstituents are primary metabolites (involved with the life cycle, thus almost the same in all living cells) and secondary metabolites (products of subsidiary pathways, thus dealing with medicinal efficacy in the case of medicinal plants). They are not usually produced under the same conditions. In most cases, the specific function of the phytocompounds and their benefits to the organism itself are not yet known; however, they possess pharmacological properties that are beneficial for humans and animals\u2019 health care systems. The distribution of secondary metabolites differs dramatically from one plant to another, and even different accessions of the same species possess varying quantities and qualities of pharmacologically active compounds [5,81\u201383]. 5.2. Phytocompounds From NS, many phytoconstituents have been extracted, validated, and reported [44]. This review looked at available information on 171 isolated phytoconstituents of NS with structure (Fig. 3), part used, extraction method and isolation techniques (Table 5). Among these metabolites, only seven compounds exhibited antimicrobial activities in experimental studies (Table 6). Only a few other compounds showed other pharmacological properties. For example, \u03b1-Hederin has potential as an anticancer agent [84]. It is effective against HEp-2 laryngeal cancer cells [85] and has antitumor properties [86]. It can also attenuate lung inflammation and improve cytokines [87]. Oleic acid and linoleic acid modulates the interaction of cardiac glycosides with the sodium pump [88], nigellidine possess immunomodulatory, anti-inflammatory and antioxidant activities [89], and longifolene is effective as an insect re- pellent [90]. But the pharmacological roles of a majority of the isolated pure compounds of NS in diverse health management are yet to be discovered, including IDs. However, the list of phytocompounds we have shown in this study might facilitate the researchers in drug dis- covery, mainly through computational biology, which can select target candidates with the highest potential for successful disease recovery using bioinformatic tools. The highest number of metabolites has been isolated from seeds, followed by roots and shoots (Fig. 4a). These compounds were in different categories: alkaloids (1\u201312), fatty acids (13\u201325), polyphenols (26\u201354), phytosterols (55\u201360), terpenes and terpenoids (61\u2013151), and others (152\u2013171). Terpenes and terpenoids were the most predominant secondary metabolites, accounting for 53% of the identified molecules. Fig. 4b shows the prevalence of different types of phytocompounds of NS. For isolation of metabolites, different types of extraction methods, such as methanolic, ethanolic, n-hexane, chloroform, ethyl acetate, diethyl ether, hot and cold water, supercritical carbon dioxide, hydro- distillation and microwave distillation, have been used for different parts of the plant (Table 5). Identification and characterization were done using various chro- matography and spectroscopy methods, including thin-layer chromatography (TLC), column chromatography (CC), gas chromatography-mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), ultra HPLC/MS-MS (UHPLC/MS-MS), reversed-phase HPLC (RP-HPLC), infrared spectroscopy (IR), nuclear magnetic resonance (NMR), mass spectrometry (MS), and X-ray crys- tallography (Table 5). 5.2.1. Alkaloids A total of 12 alkaloids (1\u201312) were isolated from the seeds. The naturally occurring alkaloids of NS mainly have an indazole ring as a nucleus, such as migellicine and nigellidine. Nigellidine-4-O-sulfite is the first sulfated alkaloid of its type. Nigellimine and nigellimine n-oxide are isoquinoline alkaloids. Several dolabellane-type diterpene alkaloids, nigellamines A1\u2013A5, were also isolated from NS [124,125]. Natural indazole-type alkaloids have only been obtained from NS, which means they are a potential taxonomic marker [126]. 5.2.2. Fatty acids NS possesses different types of fatty acids that can be determined using GC-MS. Linoleic acid is the most predominant fatty acid (56%). Oleic acid is the second-highest fatty acid present (24.6%). Palmitic acid, stearic acid, eicosadienoic acid, linolenic acid and some other acids are also present in small amounts in NS seed oil (13\u201325) [127]. The determined fatty acids were 8% of the total identified molecules. However, some of these molecules have shown potential modulating properties where the cardiac glycosides interact with the sodium pump [88]. 5.2.3. Polyphenols A total of 29 polyphenols have been identified from the seeds, roots and shoots of NS. From roots and shoots, they were identified using RP- HPLC, and from seeds using the UHPLC-MS/MS method. Among 29 polyphenols, 17 compounds were phenolic acid (26\u201342), and the other 12 were flavonoids (43\u201354). Ferulic acid and sinapinic acid were the major phenolic acid esters identified from NS seed extract. In contrast, vanillic acid was the primary phenolic compound in shoots (143.21 mg/ 100 gm DW) and roots (89.94 mg/100 gm DW). Quercetin and kaempferol are the major flavonoid glycosides identified in NS seed extract, and catechin was the most abundant compound in roots (3.4 \u00b1 0.74 mg/100 gm DW) and shoots (7.26 \u00b1 0.97 mg/100 gm DW) [128,129]. 5.2.4. Phytosterols The total sterol concentration ranges from 1993.07 mg/kg to 2887.28 mg/kg in oil extracted from NS. \u03b2-sitosterol (44\u201354%) is the major sterol in NS seed oil. Stigmasterol (16.57\u201320.92%) is the second major sterol followed by \u03b4-7-stigmasterol, \u03b4-7-avenasterol, campesterol, and cholesterol (55\u201360) [130]. 5.2.5. Terpenes and terpenoids More than 50% of compounds among the identified phyto- compounds of NS were terpenes and terpenoids (Fig. 4). We found 91 compounds belonging to the family of terpene (61\u2013151). They include mono-terpene, di-terpene, sesquiterpenes, monoterpenoid alcohols and ketone. The major terpenes\u2014TQ, trans-anethole, p-cymene, \u03b1-pinene and carvone\u2014have been identified. TQ, the primary compound of NS, has a concentration of 388.61 \u00b5g/ml [117]. 5.2.6. Others A study showed that NS comprises 21% protein, 35.5% fat, 5.5% moisture, and 3.7% ash and carbohydrate (rhamnose, xylose, and arabinose) [127]. It also contains triterpene saponin (171) (\u03b1-hederin), phenylpropanoids (eugenol, \u03b5-cinnamaldehyde) and some alkane hy- drocarbons (n-nonane, dodecanal etc.) (152\u2013171). Table 4 Chemical compositions of Nigella sativa. Compound Yield (%) Reference Essential oil 0.4\u20131.49 [77] Fixed oil 30\u201344.21 [77] Thymoquinone 26.8\u201354.8 [78] p-cymene 14.7\u201338.0 [78] Longifolene 1.2\u201310.2 [78] Thujene 1.3\u201310.1 [78] Carvacrol 0.5\u20134.2 [78] Cubebene 0.4\u20133 [78] Pinene 0.2\u20132.4 [78] Limonene 0.7\u20132.3 [78] Sabinene 0.2\u20131.6 [78] Oleic acid 25 [79,80] Palmitic acid 18 [79,80] Thymoquinone 3.5\u20138.7 mg/g [79,80] Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 7 6. Antimicrobial pharmacology of Nigella sativa Different extracts of NS, NS oil and several bioactive molecules of NS have been effective against infections caused by microbes, as supported by numerous in vitro studies. They have distinguishable antibacterial, antiviral, antifungal and anti-parasitic activities, as discussed below. 6.1. Antibacterial activity Various studies revealed the antibacterial potential of NS. In a recent Fig. 3. Chemical structure of phytoconstituents of Nigella sativa. The compounds include alkaloids (1\u201312), fatty acid (13\u201325), polyphenol (26\u201354), phytosterol (55\u201360), terpenes and terpenoid (61\u2013151), and others (152\u2013171). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 8 study, 0.5%, 1.0%, and 2.0% concentrations of NS oil were used in the agar diffusion technique against 24 spoilages, pathogenic, and lactic acid bacteria (LAB). The more effective concentration was 2.0% [131]. The lowest active concentration of NS oil was 0.5%. The concentration was not effective against Escherichia coli, E. coli O157:H7, Klebsiella pneumoniae, Pseudomonas aeruginosa, Yersinia enterocolitica, Lb. casei ssp. casei, Leu. pseudomesenteroides or Weissella paramesenteroides. The most sensitive bacterium against all concentrations of NS oils was Aeromonas hydrophila, while the most resistant bacterium type was Y. enterocolitica (Table 7). In general, the antibacterial activity of fixed oils in NS samples against pathogenic bacteria and spoilage was higher than in LABs [131]. In another study of the antimicrobial activity of ethanol and hexane extracts of NS with the agar-well diffusion method, the extract\u2019s 1.5, 3.0, 4.5, and 6.0 mg/ml concentrations were tested and compared with Fig. 3. (continued). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 9 standard antibiotics (tetracycline, erythromycin, ciprofloxacin, and ampicillin). The ethanol extract showed an antibacterial effect against both Gram-negative and Gram-positive bacteria, and the extract showed remarkable and robust activity against S. epidermidis, K. pneumonia fol- lowed by Bacillus cereus, Bacillus subtilis, E. coli, and Salmonella typhi- murium (Table 7). The extract showed the best effect against B. subtilis, followed by B. cereus and Staphylococcus epidermidis. The hexane extract was the most effective against B. subtilis, followed by S. epidermidis and B. cereus (Table 7) [132]. NS is also effective against Methicillin-resistant Staphylococcus aureus (MRSA), which is the most common pathogen encountered in laboratory practice as well as in clinics. MRSA has become a major health problem Fig. 3. (continued). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 10 Fig. 3. (continued). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 11 worldwide. There were 99 clinical isolates of MRSA and ATCC strain 25923 tested and compared with vancomycin (positive control). The study demonstrated that methanolic and chloroform NS extracts at 4 mg/disk completely inhibited MRSA strains with a significant zone size of > 12 mm. However, these strains were not inhibited at 0.5 mg/ disk [133]. An ethanol extract of NS has been evaluated in vitro against Streptococcus mutans and Streptococcus mitis. In humans, these strains are known as causative agents of dental caries. The methanolic extract of NS Fig. 3. (continued). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 12 also showed pronounced antibacterial activity (Table 7) [134]. Another study revealed that NS was effective against antibiotic-resistant Salmo- nella enterica. Amoxicillin, chloramphenicol, tetracycline, gentamicin, and ampicillin-resistant S. enterica were also inhibited by methanol extract and NS seed oil in in vitro experiments [135]. The United States\u2019 Centers for Disease Control and Prevention (CDC) listed 18 bacteria as urgent threats, severe threats and concerning threats, and listed three bacteria on the watch list [148]. Among these infectious agents, Clostridioides difficile, Pseudomonas aeruginosa, Staph- ylococcus aureus, Streptococcus pneumonia, Salmonella Typhi, Enterobac- teriaceae and Acinetobacter as antibiotic-resistant bacteria were tested against different extracts of NS. These bacteria are responsible for various serious diseases. Fluoroquinolones-resistant Clostridioides diffi- cile causes life-threatening diarrhoea. Carbapenems-resistant Pseudo- monas aeruginosa is responsible for bloodstream, surgical site, urinary tract infections, pneumonia, and chronic lung disease [149]. Fig. 3. (continued). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 13 Fig. 3. (continued). Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 14 Table 5 Phytocompounds of Nigella sativa. No. Compound Plant part Solvent used/Method Isolation and Identification Reference Alkaloid 1 Nigellidine Seed Ethanol TLC, CC [91] 2 Nigellidine-4-O-sulfite Seed Methanol NMR, MS, X-ray [92] 3 Nigellicine Seed Chloroform CC [93] 4 Nigellimine Seed Chloroform CC [94] 5 Nigellamine A1 Seed Methanol HPLC [95] 6 Nigellamine A2 Seed Methanol HPLC [95] 7 Nigellamine A3 Seed Methanol HPLC [96] 8 Nigellamine A4 Seed Methanol HPLC [96] 9 Nigellamine A5 Seed Methanol HPLC [96] 10 Nigellamine B1 Seed Methanol HPLC [95] 11 Nigellamine B2 Seed Methanol HPLC [95] 12 Nigellamine C Seed Methanol HPLC [96] Fatty acid 13 Methylnonadeca-15,17-dienoate Seed n-hexane IR NMR, MS [97] 14 Pentyl hexadec-12-enoate Seed n-hexane IR NMR, MS [97] 15 Pentyl pentadec-11-enoate Seed n-hexane IR NMR, MS [97] 16 Lauric acid Seed n-hexane GC-MS [98] 17 Myristic acid Seed n-hexane GC-MS [98] 18 Palmitic acid Seed n-hexane GC-MS [98] 19 Stearic acid Seed n-hexane GC-MS [98] 20 Oleic acid Seed n-hexane GC-MS [98] 21 Linoleic acid Seed n-hexane GC-MS [98] 22 Linolenic acid Seed n-hexane GC-MS [98] 23 Eicosadienoic acid Seed n-hexane GC-MS [98] 24 n-decanoic acid Seed MD, HD GC-MS [99] 25 Butyric acid hexadecyl ester Seed MD, HD GC-MS [99] Polyphenol 26 Vanillic acid Root, shoot Methanol RP-HPLC [100] 27 Gallic acid Root, shoot Methanol RP-HPLC [100] 28 p-dihydroxybenzoic acid Roots Methanol RP-HPLC [100] 29 Chlorogenic acid Root, shoot Methanol RP-HPLC [100] 30 Syringic acid Root, shoot Methanol RP-HPLC [100] 31 p-coumaric acid Root Methanol RP-HPLC [100] 32 Ferulic acid Root Methanol RP-HPLC [100] 33 Trans-2-hydroxycinnamic acid Root, shoot Methanol RP-HPLC [100] 34 Trans-cinnamic acid Root, shoot Methanol RP-HPLC [100] 35 4-hydroxybenzoic acid Seed Methanol UHPLC/MS-MS [101] 36 Caffeic acid Seed Methanol UHPLC/MS-MS [101] 37 5-hydroxybenzoic acid Seed Methanol UHPLC/MS-MS [101] 38 Protocatechuic acid Seed Methanol UHPLC/MS-MS [101] 39 Sinapinic acid Seed Methanol UHPLC/MS-MS [101] 40 Rosmarinic acid Seed Methanol UHPLC/MS-MS [101] 41 Salicylic acid Seed Methanol UHPLC/MS-MS [101] 42 3-hydroxybenzoic acid Seed Methanol UHPLC/MS-MS [101] 43 Epicatechin Root, shoot Methanol RP-HPLC [100] 44 Catechin hydrated Root, shoot Methanol RP-HPLC [100] 45 Quercetine Root, shoot Methanol RP-HPLC [100] 46 Apigenin Root, shoot Methanol RP-HPLC [100] 47 Amentoflavone Root, shoot Methanol RP-HPLC [100] 48 Flavone Root, shoot Methanol RP-HPLC [100] 49 Myricetin Seed Methanol UHPLC/MS-MS [101] 50 Naringenin Seed Methanol UHPLC/MS-MS [101] 51 Kaempferol Seed Methanol UHPLC/MS-MS [101] 52 Chrysin Seed Methanol UHPLC/MS-MS [101] 53 Pinocembrin Seed Methanol UHPLC/MS-MS [101] 54 Galangin Seed Methanol UHPLC/MS-MS [101] Phytosterol 55 Cholesterol Seed Hexane GC-MS [102] 56 Campesterol Seed Hexane GC-MS [102] 57 Stigmasterol Seed Hexane GC-MS [102] 58 \u03b2-sitosterol Seed Hexane GC-MS [102] 59 \u03b4-7-stigmasterol Seed Hexane GC-MS [102] 60 \u03b4-7-avenasterol Seed Hexane GC-MS [102] Terpenes and Terpenoid 61 Camphene Seed MD, HD GC-MS [99] 62 Trans- \u03b2 \u2013terpineol Seed MD, HD GC-MS [99] 63 Linalool Seed MD, HD GC-MS [99] 64 Camphor Seed MD, HD GC-MS [99] 65 \u03b2-pinene oxide Seed MD, HD GC-MS [99] 66 Cis-pinocarveol Seed MD, HD GC-MS [99] 67 \u03b1-terpineol Seed MD, HD GC-MS [99] 68 Nerol Seed HD GC-MS [103] 69 \u03b1-pinene Seed n-hexane GC-MS [98] (continued on next page) Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 15 Table 5 (continued ) No. Compound Plant part Solvent used/Method Isolation and Identification Reference 70 Fenchone Seed n-hexane GC-MS [98] 71 Dihydrocarvone Seed n-hexane GC-MS [98] 72 Carvone Seed n-hexane GC-MS [98,99] 73 Thymoquinone Seed n-hexane GC-MS [98,99,104] 74 Terpinen-4-ol Seed n-hexane GC-MS [98] 75 Umbellulone Seed MD, HD GC-MS [99] 76 p-cymene-8-ol Seed n-hexane GC-MS [98] 77 Carvacrol Seed n-hexane GC-MS [98] 78 \u03b1-ionone Seed MD, HD GC-MS [99] 79 \u03b1 -longipinene Seed n-hexane GC-MS [98,104] 80 Longifolene Seed n-hexane GC-MS [98,99] 81 (Z)-caryophyllene Seed Sup-CO2 GC-MS [104] 82 Cyclosativene Seed Sup-CO2 GC-MS [104] 83 \u03b1 -copaene Seed Sup-CO2 GC-MS [104] 84 \u03b1 -longicyclene Seed Sup-CO2 GC-MS [104] 85 Aromadendrene Seed Sup-CO2 GC-MS [104] 86 2,4,(10)-thujadiene Seed Sup-CO2 GC-MS 87 Dihydrofarnesyl acetate Seed Sup-CO2 GC-MS [104] 88 Pimaradiene Seed Sup-CO2 GC-MS [104] 89 Myrcene Seed n-hexane GC-MS [98] 90 p-cymene Seed n-hexane GC-MS [98] 91 Limonene Seed n-hexane GC-MS [98,104] 92 \u0393-terpinene Seed n-hexane GC-MS [98] 93 Terpinolene Seed Sup-CO2 GC-MS [104] 94 1,5,8-p-menthatriene Seed Sup-CO2 GC-MS [104] 95 Thymohydroquinone dimethylether Seed Sup-CO2 GC-MS [104] 96 Thymohydroquinone methyl ether Seed Sup-CO2 GC-MS [104] 97 Citronellyl acetate Seed Sup-CO2 GC-MS [104] 98 Ocimenone (E) Seed Sup-CO2 GC-MS [104] 99 \u03b2-farnesene Seed MD, HD GC-MS [99] 100 \u03b1 -phellandrene Seed n-hexane GC-MS [98] 101 Trans-\u03b1-bergamotene Seed MD, HD GC-MS [99] 102 Thymohydroquinone Seed MD, HD GC-MS [99] 103 Tricyclene Seed Sup-CO2 GC-MS [104] 104 \u03b1-terpinene Seed Sup-CO2 GC-MS [104] 105 p-cymenene Seed MD, HD GC-MS [99] 106 Trans-sabinene hydrate acetate Seed MD, HD GC-MS [99] 107 1,8-cineole Seed Sup-CO2 GC-MS [104] 108 Cis-sabinene hydrate Seed Sup-CO2 GC-MS [104] 109 Trans-sabinene hydrate Seed Sup-CO2 GC-MS [104] 110 Borneol Seed Sup-CO2 GC-MS [104] 111 Pinocarvone Seed Sup-CO2 GC-MS [104] 112 Trans-dihydrocarvone Seed Sup-CO2 GC-MS [104] 113 Myrtenol Seed MD, HD GC-MS [99] 114 Iso-dihydrocarveol Seed MD, HD GC-MS [99] 115 Trans-carveol Seed MD, HD GC-MS [99] 116 Cis-carveol Seed MD, HD GC-MS [99] 117 Cuminaldehyde Seed MD, HD GC-MS [99] 118 Geranial Seed MD, HD GC-MS [99] 119 Bornyl acetate Seed MD, HD GC-MS [99] 120 p-cymen-7-ol Seed MD, HD GC-MS [99] 121 Thymol Seed MD, HD GC-MS [99] 122 Methyl geranate Seed MD, HD GC-MS [99] 123 Cis-carvyl acetate Seed MD, HD GC-MS [99] 124 Neryl acetate Seed MD, HD GC-MS [99] 125 Geranyl acetone Seed MD, HD GC-MS [99] 126 \u03b1 -curcumene Seed MD, HD GC-MS [99] 127 Sabinene Seed n-hexane GC-MS [98,104] 128 Cis-piperitol Seed MD, HD GC-MS [99] 129 Trans-piperitol Seed MD, HD GC-MS [99] 130 Iso-longifolene Seed MD, HD GC-MS [99] 131 \u03b2-Elemene Seed MD, HD GC-MS [99] 132 Estragole Seed n-hexane GC-MS [98] 133 Anisaldehyde Seed n-hexane GC-MS [98] 134 Trans-anethole Seed n-hexane GC-MS [98] 135 \u03b3-Elemene Seed MD, HD GC-MS [99] 136 Myristicin Seed n-hexane GC-MS [98] 137 Apiole Seed n-hexane GC-MS [98] 138 Cis-thujopsene Seed MD, HD GC-MS [99] 139 Davanone Seed Sup-CO2 GC-MS [104] 140 \u03b1-longifolene Seed Sup-CO2 GC-MS [104] 141 \u03b2-caryophyllene Seed Sup-CO2 GC-MS [104] 142 (Z,E)-farnesyl acetate Seed MD, HD GC-MS [99] 143 (E,E)-farnesyl acetate Seed MD, HD GC-MS [99] 144 \u03b2 -bisabolol Seed MD, HD GC-MS [99] 145 \u03b1-zingiberene Seed MD, HD GC-MS [99] (continued on next page) Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 16 Streptococcus pneumonia shows resistance to various antibiotics and is responsible for bacterial pneumonia, meningitis, bloodstream in- fections, and ear and sinus infections. NS essential oil and other phy- tochemicals (TQ, p-cymene, carvacrol) can modify the resistance potentiality of AMR bacteria and become sensitive. NS could be an excellent source of new antibacterial agents to achieve AMR stewardship. 6.1.1. Mode of actions against bacteria Gram-positive and Gram-negative bacteria have multidrug efflux pumps (EPs), which assist bacterial populations to enhance their im- munity and survive when exposed to antimicrobial substances. The leading cause of MDR bacteria is EPs, a transporter of proteins involved in the removal of drugs and toxic substances to the external environment from the interior of the cell (Fig. 5a) [150,151]. In Listeria mono- cytogenes, two efflux pumps have been identified [152]. One efflux pump called MdrL extrudes macrolides, cefotaxime, heavy metals, and EtBr. The other, Lde, extrudes fluoroquinolone, acridine orange, and EtBr [153,154]. NS oil, TQ, carvacrol, and its active compounds are efficient modulators of antibiotic resistance in L. monocytogenes. TQ and essential oil inhibit efflux pumps, increase the accumulation of antibiotics in the bacterial cells, and at lower doses, enhance their effectiveness [23]. TQ also intervenes in its antibacterial effect by producing ROS, prompting oxidative stress and cell apoptosis (Fig. 5b) [22]. On the other hand, p-cymene has no antimicrobial activity. However, it increases the membrane permeability, thereby promoting the influx of antimicrobial substances [23]. 6.2. Antiviral and potential anti-SARS-CoV-2 effects with the mode of actions NS increases the helper T cell (T4 and T8) suppressor ratio and natural killer cells (NK) cell activity. It results in improved immunity, so shows a suppressing effect against human immune deficiency virus protease [44]. NS exhibits anti-influenza virus activity. It plays a pivotal role in diminishing the pathogenic effects by inducing efficient immune Table 5 (continued ) No. Compound Plant part Solvent used/Method Isolation and Identification Reference 146 \u03b2 -bisabolene Seed MD, HD GC-MS [99] 147 6-methyl- \u03b1-(E)-ionone Seed MD, HD GC-MS [99] 148 \u03b4-cadinene Seed MD, HD GC-MS [99] 149 \u03b3-himachalene Seed MD, HD GC-MS [99] 150 \u03b1-humulene Seed MD, HD GC-MS [99] 151 \u03b1-himachalene Seed MD, HD GC-MS [99] Others 152 Eugenol Seed MD, HD GC-MS [99] 153 Methyl eugenol Seed MD, HD GC-MS [99] 154 (E)-cinnamaldehyde Seed MD, HD GC-MS [99] 155 n-nonane Seed n-hexane GC-MS [99] 156 3-methyl nonane Seed n-hexane GC-MS [98] 157 Dodecanal Seed MD, HD GC-MS [99] 158 Iso-longifolol Seed MD, HD GC-MS [99] 159 n-decane Seed n-hexane GC-MS [98] 160 1-methyl-3-propyl benzene Seed n-hexane GC-MS [98] 161 1-ethyl-2,3-dimethyl benzene Seed n-hexane GC-MS [98] 162 n-tetradecane Seed n-hexane GC-MS [98] 163 n-hexadecane Seed n-hexane GC-MS [98] 164 2-undecanone Seed Sup-CO2 GC-MS [104] 165 Benzaldehyde Seed MD, HD GC-MS [99] 166 Coumarin Seed MD, HD GC-MS [99] 167 Citronellyl n-butyrate Seed MD, HD GC-MS [99] 168 (Z)-isoeugenol acetate Seed MD, HD GC-MS [99] 169 Tetradecanal Seed MD, HD GC-MS [99] 170 Methyl linoleate Seed MD, HD GC-MS [99] 171 \u03b1-hederin Seed Ethyl acetate CC5 [105] CC: Column chromatography, HPLC: High performance liquid chromatography; GC-MS: Gas Chromatography-Mass Spectrometry, MD: Microwave distillation, HD: Hydro-distillation, TLC: Thin layer chromatography, Sup-CO2: Super critical carbon dioxide, IR: Infrared spectroscopy, NMR: Nuclear magnetic resonance, MS: Mass Spectrometry, UHPLC/MS-MS: Ultra HPLC/MS-MS, RP-HPLC: Reversed-phase HPLC. Table 6 Antimicrobial phytoconstituents of Nigella sativa. No. Compound Antimicrobial activity Other pharmacological activities 1. Thymoquinone Antibacterial [106,107], Antidermatophytic activity [108,109], Antifungal [110], Act as putative efflux pump inhibitors in Listeria monocytogenes [111] Antiinflammatory [112, 113], anticancer, antitumor [114], Anticonvulsant effect [115], antileishmanial effects [116], anti-proliferative effect [117], Effective against HEp-2 laryngeal cancer cells [85], anti-inflammatory activities of TQ in PDA (pancreatic ductal adenocarcinoma) cells, [118], TQ as an inducer of cell cycle arrest and apoptosis in human colon cancer HCT-116 cells [119], Antioxidation activity [120], Antinociceptive effects [121] 2. \u03b1-pinene Bactericides [122] Insect repellents [90] 3. p-cymene Antimicrobial [123], Bactericides [122] Insect repellents [90] 4. Longifolene Insect repellents [90] 5. Thymol Antifungal [110] Anti-inflammatory [113] 6. Carvacrol Act as putative efflux pump inhibitors in Listeria monocytogenes [111] - 7. Thymohydroquinone Antibacterial activity [107], Antifungal activity [110] - Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 17 responses [155]. Patients suffering from hepatitis C virus (HCV) infec- tion exhibited notable improvement in HCV viral load using oil extrac- ted from NS seed [69]. Regaining and seroreversion of HIV-positive patients can be achieved by using NS seeds [156]. NS oil potentially binds with murine cytomegalovirus that showed inhibition of viral growth in a rat model [157]. The ethanolic extracts of NS successfully reduced the viral load and death in embryonic chicken eggs against the Newcastle disease virus [158]. Recent studies revealed that NS has a high potential as a herbal antiviral agent against novel coronavirus [159]. DL-Arabinose is an important phytochemical found in NS with effective antiviral activity [160]. A recent study suggested that NS could be considered a natural substitute for chloroquine because it contains several bioactive compo- nents such as TQ, dithymoquinone, thymohydroquinone, and nigelli- mine activity, augmented by a Zn supplement [161]. Another in-silico study by molecular docking suggested that nigerlidine and \u03b1-hederin are the main compounds from NS that can prevent COVID-19 with the same or better score than drugs under clinical trials [162]. In another in-silico study, nigellidine showed the highest binding affinity to N terminus protease (\u2212 7.61) and nucleocapsid and the main protease necessary for viral maturation in protein structures, RNA packaging, and other func- tions. Moreover, binding to IL1 and TNF-\u03b1 receptors may reduce cyto- kine storm after viral infection [24]. \u03b1-hederin (\u2212 6.265 kcal/mol) and thymohydroquinone (\u2212 5.466 kcal/mol) are identified as suitable bind- ing ligands to ACE2 receptors in the human system responsible for virus entry [25]. Among other compounds, dithymoquinone (DTQ), also known as nigellone, shows a binding affinity of \u2212 8.6 kcal/mol compared to a positive control (chloroquine, \u2212 7.2 kcal/mol), and has the promising ability of binding at the SARS-CoV-2:ACE2 interface to disrupt viral host interaction [159]. Oral administration of honey with NS reduced the severity of clinical symptoms, earlier viral clearance, and reduced mortality in COVID-19 patients [163]. Taibah University started a novel evidence-based approach, \u201cTaibUVID\u201d, for COVID-19 treatment. A single TaibUVID dose includes one large spoonful of Nigella sativa oil (or 2 g of Nigella sativa seeds) mixed with one gram of ground anthemis hyaline and one large spoonful of natural honey. This mixture is to be chewed in the mouth and swallowed orally for COVID-19 close contacts and patients. It Fig. 4. Phytoconstituents of Nigella sativa. (a) shows different parts of N. sativa that are used for the isolation of compounds, (b) shows types of identified compounds (IC) and the percent value of each type of identified compound. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 18 Table 7 In vitro antibacterial activity of Nigella sativa extracts. Plant part Extract No. test MOs Inhibited MOs Type MEIC MIC ZOI (mm or %) Remarks Reference Seed n-H 24 A. hydrophila ATCC 7965* -ve 2% ND 37.5 mm [131] B. cereus FMC 19 +ve 29.5 mm B. subtilis IMG 22 +ve 27 mm Corynebacterium xerosis UC 9165 +ve 32.5 mm Enterobacter aerogenes CCM 2531 -ve 23.6 mm Enterococcus faecalis ATCC 15753 +ve 19.5 mm E. coli DM -ve 19.3 mm E. coli O157:H7 KUEN 1461 -ve 24 mm K. pneumoniae FMC 5 -ve 18.8 mm Listeria monocytogenes Scott A +ve 21.5 mm Mycobacterium smegmatis RUT +ve 32.2 mm Proteus vulgaris FMC 1 -ve 35 mm P. aeruginosa ATCC 27853 -ve 21.2 mm Pseudomonas fluorescens EU -ve 21.4 mm S. typhimurium -ve 24.4 mm S. aureus Cowan 1 -ve 29.5 mm Y. enterocolitica EU +ve 16.5 mm Streptococcus salivarius +ve 24 mm Lactobacillus delbrueckii +ve 24.5 mm Lb. casei ssp. casei K64 +ve 20.8 mm Lactobacillus. Paracasei +ve 21 mm Leu. pseudomesenteroides E83 +ve 19.3 mm Leuconostoc gelidum E26 +ve 19.6 mm Weissella paramesenteroides E95 +ve 23.3 mm Seed E 8 S. epidermidis* +ve 6 mg/ml ND 15 mm NoA against P. aerogenosa and E. aerogens [132] K. pneumonia -ve ND B. cereus +ve 8.0 mm B. subtilis +ve 7.0 mm E. coli -ve ND S. typhimurium -ve 9.0 mm n-H S. epidermidis +ve 19 mm NoA against P. aerogenosa, E. aerogens, E. coli and S. typhimurium K. pneumonia -ve ND B. cereus +ve 11 mm B. subtilis +ve 26 mm Seed CHCl3, M 99 S. aureus +ve 4 mg/disc 0.2\u20130.5 mg/ml > 12 mm [133] Seed M 2 S. mutans +ve ND ND 12.7 mm [134] S. mitis +ve 10.4 mm Seed EO 1 S. enetrica -ve ND > 1000\u00b1322.7 \u03bcg/ ml 20\u201314 mm [135] M S. enetrica -ve ND \u2265 562.5 \u03bcg/ml 35\u201317 mm Seed M 5 S. aureus* +ve 100 mg/ml ND 25 mm NoA againstE. coli, K. pneumonia and B. cereus [136] P. aeruginosa -ve 21 mm Seed CHCl3 6 S. aureus ATCC 103207 +ve 18 mg/ml ND 19 mm NoA againstV. cholerae El Tor and K. pneumoniae ATCC 13883 [137] B. cereus ATCC 6623 +ve 16 mm B. subtilis ATCC 27853 +ve 26 mm Vibrio cholerae El Tor -ve 20 mm S. aureus ATCC 103207 +ve 26 mm B. cereus ATCC 6623 +ve 25 mm E B. subtilis ATCC 27853 +ve 28 mm NoA against K. pneumoniae ATCC 13883 E. coli ATCC 12079 -ve 21 mm V. cholerae El Tor -ve 24 mm Seed E 4 B. subtilis +ve ND 12.5 mg/ml 18 mm [29] S. aureus +ve 16 mm E. coli -ve 20 mm P. aeruginosa -ve 16 mm Seed M 2 S. mutans* +ve ND 0.2 mg /ml 22.3 mm [138] (continued on next page) Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 19 is a promising evidence-based approach to decrease fatalities and rapidly end the COVID-19 pandemic [164]. 6.3. Antifungal effects with the mode of actions NS has an inhibitory effect against different pathogenic yeasts (Table 8). The presence of \u03b2-sitosterol and oleic acid in the oil compo- sition of NS is considered to be responsible for its antifungal activity [165]. In addition, S. Gupta [166] stated that different components of NS oil, such as stigmasterol and \u03b2-sitosterol, show antifungal properties against some pathogenic yeasts such as Candida tropicalis, Candida albicans, and Geotrichum candidum. An in vivo study in mice showed an antifungal activity of NS seeds\u2019 aqueous extract against Candida albicans responsible for candidiasis [167]. Another study [168] showed that the candidacidal pathway in mice neutrophils is nitric oxide (NO)-depend- ent. There is a possibility that the active ingredient(s) of the plant extract may stimulate granulocytes and monocytes to form nitric oxide, leading to excellent antifungal activity, which in turn kills C. albicans [169]. The Table 7 (continued ) Plant part Extract No. test MOs Inhibited MOs Type MEIC MIC ZOI (mm or %) Remarks Reference Lactobacillus acidophilus +ve 05 mg/ml 18.6 mm H2O S. mutans* +ve 0.3 mg /ml 15.3 mm L. acidophilus +ve 0.3 mg/ml 12.3 mm Seed EA 2 S. aureus* +ve ND 62.5 \u03bcg/ml 10.6 mm [139] Propionibacterium acnes +ve ND 9.0 mm Seed EO 1 Chlamydia trachomatis D -ve ND 6.25 and 3.12 \u03bcM ND MIC of carvacro, thymol was 6.25 and p-cymene, TQ was 3.12 \u00b5M [140] Seed DEE 4 S. aureus +ve 25\u2013400 \u03bcg /disc ND 21 mm S. typhimurium was resistant [141] E. coli -ve 25 mm P. aeruginosa -ve 25 mm Seed M 2 E. coli -ve 1.2 g/kg ND 100 % [142] S. aureus +ve 2.14 g/kg 87.5 % CHCl\u2083 E. coli -ve 2.6 mg/kg 100 % S. aureus +ve 2.6 mg/kg 100 % EO E. coli -ve 0.3 g/kg 100 % S. aureus +ve 0.3 g/kg 100 % Seed, fruit cH2O 5 E. coli* -ve ND ND 23 mm [143] P. aeruginosa -ve 23 mm Salmonella typhi -ve 23 mm E. faecalis +ve 23 mm hH2O E. coli* -ve 22 mm P. aeruginosa -ve 22 mm Salmonella typhae -ve 22 mm E. faecalis +ve 22 mm M E. coli* -ve 23 mm NoA against S. aureus P. aeruginosa -ve 23 mm Salmonella typhae -ve 23 mm E. faecalis +ve 23 mm Seed M 6 E. coli* -ve ND 1.125 mg/ml ND NoA against B. cereus [144] P. aeruginosa -ve 1.125 mg/ml S. aureus* +ve 0.56 mg/ml S. typhi -ve 1.125 mg/ml B. subtilis +ve 1.125 mg/ml E P. aurigenisa -ve 1.125 mg/m NoA against E. coli S. aureus +ve 0.56 mg/ml S. typhi* -ve 1.125 mg/ml B. cereus +ve 1.125 mg/ml B. subtilis +ve 1.125 mg/ml TQ DMSO, H2O 4 Clostridium difficile* +ve 160 \u03bcg/ml 10\u201340 \u03bcg/ml ND [145] Clostridium perfringens +ve 80\u2013160 \u03bcg/ml Bacteroides fragilis -ve 80\u2013160 \u03bcg/ml Bacteroides thetaiotaomicron -ve 80\u2013160 \u03bcg/ml Seed M 2 Porphyromonas gingivalis -ve 50 mg/ml 25 mg/ml 5.4 mm [146] Prevotella intermedia -ve 25 mg/ml 10.1 mm Seed E 1 Streptococcus pyogenes +ve ND 12.5 mg/ml 6.33 mm [30] Plant powder E 3 K. pneumoniae -ve 50 mg/100 ml ND 14 mm [32] Acinetobacter baumannii* -ve 17 mm P. aeruginosa -ve 11 mm Seed M 4 S. pyogenes* +ve 50 mg/ml ND 19 mm [147] P. aeruginosa -ve 15 mm K. pneumoniae -ve 15 mm P. vulgaris -ve 15 mm *Antibiotic resistant species, \u01c2Indirect immunofluorescence assay. Other test assays were disc diffusion method; MEIC: Most effective inhibitory concentration; MIC: Minimum inhibitory concentration; MOs: Number of test microorganisms; ND: Not determined; ZOI: Zone of Inhibition, DMSO: Dimethylsulfoxide, EO: Essential Oil, EA: Ethyl acetate, TQ: Thymoquinone, CHCl3: Chloroform, cH2O: Cold water, hH2O: Hot water, M: Methanol, E: Ethanol, DEE: Diethyl ether, NoA: No activity, +ve: Positive bacteria, -ve: Negative bacteria. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 20 anti-yeast activity of NS seed extract is maximised at pH 7 and 30 \u25e6C [170]. The essential oil of NS possesses higher antidermatophytic activity [175]. Furthermore, an ether extract of NS seed and its active compo- nent TQ showed some antifungal activity against dermatophytes: four species of Trichophyton rubrum and one each of T. interdigitale, T. mentagrophytes, Microsporum cani, and Epidermophyton floccosum. The minimum inhibitory concentration (MIC) of the ether extract of NS was between 10 and 40 mg/ml, while that of TQ was 0.125 and 0.25 mg/ml, inhibiting 80\u2013100% fungal growth. [176]. NS oil exhibited significant effectiveness against non-dermatophytic filamentous fungi such as Drechslera hawiinesis, Alternaria alternate, and F. moniliforme, which were Fig. 5. Mechanism of antibiotic resistance modulation by Nigella sativa. A) L. monocytogenes extrude macrolides, cefotaxime, heavy metals, EtBr and MdrL and fluoroquinolone, acridine orange, EtBr by Lde efflux pump on the bacterial cell surface. B) EO, TQ, Car modulate MdrL and Lde efflux pump and inhibit to extrude antibiotics. TQ also increases ROS generation, which prompts oxidative stress and cell demise. P-cymene increases the membrane permeability and increasing the influx of antimicrobial substances. EtBr: Ethidium Bromide, EO: Essential oil, TQ: thymoquinone, Car: carvacrol. Table 8 Antifungal activity of Nigella sativa. Fungus Extract Method MIC Reference Pathogenic yeasts C. albicans Essential oil BM 2300 \u03bcg/ml [171] Essential oil BM IC90: 4.916 mg/ml [165] C. dubliniensis Essential oil BM IC90: 5.183 mg/ml [165] C. glabrata Essential oil BM IC90: 5.992 mg/ml [165] C. krusei Essential oil BM IC90: 4.939 mg/ml [165] Dermatophytes Trichophyton mentagrophytes Essential oil BM 2 \u00b1 0.6 mg/ml [172] Ether ADD 40 mg/ml [173] Methanol BM 8 mg/ml [108,123] Aqueous BM IC50: 16 mg/ml [108] Trichophyton rubrum Essential oil BM 4 \u00b1 1.1 mg/ml [172] Ether ADD 40 mg/ml [173] Epidermophyton floccosum Essential oil BM 2 \u00b1 0.6 mg/ml [172] Ether ADD 40 mg/ml [173] Microsporum gypseum Essential oil BM 2 \u00b1 0.6 mg/ml [172] Methanol BM IC50: 4 mg/ml [108] Aqueous BM IC50: 8 mg/ml [108] Microsporum canis Essential oil BM 4 \u00b1 1.1 mg/ml [172] Methanol BM IC50: 4 mg/ml [108] Aqueous BM IC50: 8 mg/ml [108] Ether ADD 10 mg/ml [173] Trichophyton interdigitale Ether ADD 40 mg/ml [173] Non-dermatophyte filamentous fungi Aspergillus fumigatus Essential oil BM IC90: 1.5 mg/ml [174] BM IC90: 1.5 mg/ml A. flavus Essential oil BM IC90: 1.5 mg/ml [174] BM IC90: 2 mg/ml BM: Broth-Macrodilution, ADD: Agar Disk Diffusion, MIC: Minimum Inhibitory Concentration, IC50: Half-maximal inhibitory concentration, IC90: Ninety percent- maximal inhibitory concentration. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 21 inhibited entirely at 0.1% and 0.15% concentration [177]. In a study, NS showed maximum inhibition (76.1%) at 10% con- centration against Macrophomina phaseolina, one of the most damaging phytopathogenic fungi causing charcoal rot disease (Iqbal et al., 2014). Ns-D1 and Ns-D2 are two novel antifungal defensins, isolated from seeds of NS, that exhibit intense divergent antifungal activity towards several phytopathogenic fungi [178]. The essential oil of NS (1.5 mg/ml) inhibits the production of mycelia (67.4%) and aflatoxin in Aspergillus parasiticus [26]. A study by Khosravi indicated that when Aspergillus flavus and Aspergillus fumigates were exposed to NS oils (2 mg/ml), they exhibited detachment of the fibrilar layer of the cell wall. The researcher also observed that the plasma membrane was separated from the cell wall, the cytoplasm was disrupted, and subsequently the cytoplasm was vacuolated, before the vacuole fused. Overall, oil from NS showed moderate to weak activity against aflatoxin-producing fungi [179]. 6.4. Anti-parasitic activity with the mode of actions Studies have indicated that NS possesses significant anti-parasitic (anti-helminths, anticestodals, and anti-schistosomal) properties. NS seeds showed significant anticestodal activities. These easy-to-grow and affordable indigenous plant-based drugs are safe agents for treating children with roundworm and tapeworm infestations. The most effective oral doses were 40 and 50 mg per kg of body weight with no serious adverse effects [180]. The methanolic extract of NS seeds (1250 mg/kg) suppressed Plasmodium yoelii infection at a suppression rate of 94%, whereas the most effective synthetic drug, chloroquinone, had an 86% suppression rate. A 400 mg/kg of aqueous suspensions and oil emulsions of NS seeds were used to treat coccidiosis in rabbits. The emulsion has higher concentrations of alkaloid nigellicine that has a deadly influence on parasites [181]. NS oil effectively reduced the number of Schistosoma mansoni worms in the liver and reduced the total number of ova that accumulated in both the intestine and the liver. It has also been shown to be effective against other helminths such as Hymenolepis nana [182]. NS was tested against cercariae, miracidia, and adult worms of Schistosoma mansoni. It has demonstrated strong biocidal activity against all the stages of the parasite as well as an effect on the egg-laying activity of the adult female worms [28]. However, the molecular mechanisms of biocidal action of NS against parasites are yet be investigated. 7. Safety and toxicity TQ is the main constituent of the volatile oil of NS seeds. Its seed extract and its constituents appear to have a low level of toxicity [31]. After oral administration of TQ, the demonstrated toxicity level was negligible. Oral TQ is bio-transformed into more minor toxic metabolites in the gastrointestinal tract or metabolized in the liver into dihydro-thymoquinone. After administration, the toxicity increases due to the complete absorption of TQ into the systemic circulation [183]. The treatment of male albino rats with an intraperitoneal administration of phosphate-buffered saline (PBS) or 200 mg/kg cyclophosphamide and then intragastric administration of NS oil or TQ on alternate days for 12 days, initiated 6 h before or after a cyclophosphamide injection, showed that the treatment with cyclophosphamide induced significant toxicity while treatment with NS oil or TQ induced a significant reduc- tion in overall toxicity [184]. The high values of oral and intraperitoneal lethal doses of NS fixed oil at 28.8 ml/kg of body weight show its low acute toxicity [185]. No toxicity was observed when NS oil was administered in different doses up to 10 ml/kg of body weight [186]. The acute toxicity of TQ is relatively low, and it is well-tolerated, generally, when given sub-chronically in drinking water at doses that are about 12 times the cytoprotective dose [187]. Another study involved oral administration of the aqueous, chloroform, and methanol extracts of NS seeds, in 6, 9, 14, and 21 g/kg. The methanol extracts in all four doses and chloroform extract at 21 g/kg significantly decreased animals\u2019 weight. The study of the hepatic toxicity of the extracts at 6 g/kg/day for 14 consecutive days, as well as a hepatic histological study, revealed no abnormal activity of ALP, SGPT, and SGOT in blood [188]. The supplementation of NS up to 1 g/kg for 28 days produced no changes in liver enzyme level and no toxicity effect on liver function [189]. TQ is beneficial for the prevention and protection of cisplatin nephrotoxicity in rodents. The oral administration of TQ (50 mg/L in drinking water) for five days before and five days after a single injection of cisplatin (5 mg/L in rats and 7 or 14 mg/l in mice) also greatly improved cisplatin-induced nephrotoxicity [190]. The subacute toxicity evaluations of the aqueous, chloroform and methanol extracts of NS at 6 g/kg showed no toxicity. However, the chronic toxicity study found slightly toxic 2 ml/kg NS fixed oil [191]. The high antioxidant potential of TQ is responsible for the reduction in related nephropathy toxicity [184]. 8. Challenges and future directions NS has shown promising results against numerous chronic IDs, yet further investigation should be conducted using human clinical trials with standardized preparation and verification for its full therapeutic potency. Further in silico studies, preclinical, experimental evidence, and prospective studies are proposed to evaluate the phytotherapy potential of NS, particularly for emerging and novel diseases such as COVID-19. NS oil and essential oils for topical anti-ageing skincare formulations are also recommended due to their various pharmacological activities such as antioxidant, anti-ageing, antibacterial, anti-inflammatory, anti- carcinogenic, anti-allergy, and moisturizing properties. Other novel extraction techniques, such as natural deep eutectic solvents, could be explored to identify new compounds from the various parts of NS plants, especially the seed. 9. Conclusion This review presents a succinct summary of the antimicrobial effects of NS, a medieval armamentarium worth further clinical exploration in modern medicine. Various crude extracts from different solvents have been reportedly established as antibacterial, antifungal, antiviral, and anti-parasitic agents. NS oil, TQ, carvacrol, and other active compounds are efficient modulators of AMR bacteria. NS oil and TQ inhibited efflux pumps, resulting in the high accumulation of antibiotics in bacterial cells. Ultimately bacteria become sensitive and die. This action can be valid even at lower doses. TQ facilitates the production of ROS, pro- motes oxidative stress, and thereby occurs cell apoptosis. Another potent compound of NS, p-cymene increases the bacterial membrane perme- ability, thereby promoting the influx of antimicrobial substances. NS oil, TQ, carvacrol and p-cymene could be potential antibacterial agents. Phytochemicals, nutritionally vital constituents, PUFA as well as highly active volatile compounds such as p-cymene, TQ, \u03b1-thujene, carvacrol, \u03b2-pinene, limonene, methyl linoleate, sabinene, D-limonene, 4,5-epoxy- 1-isopropyl-4- methyl-1-cyclohexene, and 4-terpineol found in NS could exert a medicinal value when processed and used correctly. Funding This research received no external funding. Institutional review board statement Not applicable. Informed consent statement Not applicable. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 22 Data availability statement Data is contained within the article. CRediT authorship contribution statement MSH, AS, AD, MAM, AA, IAA, and ZU prepared the manuscript. MSH, LCM, BHG and MMRS critically edited the draft. AS, AD, MAM, and AA prepared chemical structure. MSH and LCM supervised and critically evaluated the manuscript for scientific quality. MSH conceptualized, designed the diagrams, and project administration. All authors read the manuscript and approved it. Conflict of interest statement The authors declare no conflict of interest. Data availability Data is contained within the article. Acknowledgments Authors are grateful to Rabyea Jahan Mukti for her artwork (Fig. 1) included in this study which added a great value in understanding the Nigella sativa\u2019s anatomy. References [1] WHO, Antimicrobial resistance, 2020. https://www.who.int/news-room/fact -sheets/detail/antimicrobial-resistance. (Accessed 9 August 2020. [2] H. Karuniawati, M.A.A. Hassali, S. Suryawati, W.I. Ismail, T. Taufik, M. S. Hossain, Assessment of knowledge, attitude, and practice of antibiotic use among the population of boyolali, Indonesia: a cross-sectional study, Int. J. Environ. Res. Public Health 18 (16) (2021) 8258. [3] Z. Urbi, N.S. Azmi, M.S. Hossain, Antimicrobial Role of Glycosaminoglycans: Beyond Bacterial Adhesion to Host Cell, The 1st International Electronic Conference on Antibiotics, MDPI, Basel, Switzerland, 2021. [4] D.A. Gray, M. Wenzel, Multitarget approaches against multiresistant superbugs, ACS Infect. Dis. 6 (6) (2020) 1346\u20131365. [5] M.A. Hannan, M.A. Rahman, A.A.M. Sohag, M.J. Uddin, R. Dash, M.H. Sikder, M. S. Rahman, B. Timalsina, Y.A. Munni, P.P. Sarker, M. Alam, M. Mohibbullah, M. N. Haque, I. Jahan, M.T. Hossain, T. Afrin, M.M. Rahman, M. Tahjib-Ul-Arif, S. Mitra, D.F. Oktaviani, M.K. Khan, H.J. Choi, I.S. Moon, B. Kim, Black cumin (Nigella sativa L.): a comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety, Nutrients 13 (6) (2021). [6] W.F. Taylor, M. Yanez, S.E. Moghadam, M. Moridi Farimani, S. Soroury, S. N. Ebrahimi, M. Tabefam, E. Jabbarzadeh, 7-epi-clusianone, a multi-targeting natural product with potential chemotherapeutic, immune-modulating, and anti- angiogenic properties, Molecules 24 (23) (2019). [7] S. Hossain, Z. Urbi, H. Karuniawati, R.B. Mohiuddin, A. Moh Qrimida, A.M. M. Allzrag, L.C. Ming, E. Pagano, R. Capasso, Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy, Life 11 (4) (2021), 348, https:// doi.org/10.3390/life11040348. [8] Z. Urbi, Z. Zainuddin, Standardization of surface sterilization protocol of field grown Stevia rebaudiana prior to in vitro clonal propagation, J. Teknol. 77 (24) (2015). [9] U. Farooq, T. Khan, S.A. Shah, M.S. Hossain, Y. Ali, R. Ullah, N. Raziq, M. Shahid, R. Capasso, Isolation, characterization and neuroprotective activity of folecitin: an in vivo study, Life 11 (8) (2021) 825. [10] N.A. Ismail, M.S. Hossain, N.H. Mohd Mustafa, I. Chia, Phang, morpho- physiological characteristics, selected macronutrient uptake, and oxidative stress level of Andrographis paniculata under saline condition, J. Teknol. 77 (24) (2015) 135\u2013140. [11] J.A. Duke, P.-A.K. Duke, J.L. duChellie, Duke\u2019s Handbook of Medicinal Plants of the Bible, CRC Press, New York, 2008. [12] E. Yarnell, K. Abascal, Nigella sativa: holy herb of the middle east, Altern. Complement. Ther. 17 (2) (2011) 99\u2013105. [13] M.R. Khazdair, Z. Gholamnezhad, R. Rezaee, M.H. Boskabady, A qualitative and quantitative comparison of Crocus sativus and Nigella sativa immunomodulatory effects, Biomed. Pharm. 140 (2021), 111774. [14] H. Alkis, E. Demir, M.R. Taysi, S. Sagir, S. Taysi, Effects of Nigella sativa oil and thymoquinone on radiation-induced oxidative stress in kidney tissue of rats, Biomed. Pharm. 139 (2021), 111540. [15] H. Omidi, S. Khorram, M. Mesgari, M. Asghari-Jafarabadi, A. Tarighat-Esfanjani, Effects of separate and concurrent supplementation of nano-sized clinoptilolite and Nigella sativa on oxidative stress, anti-oxidative parameters and body weight in rats with type 2 diabetes, Biomed. Pharm. 96 (2017) 1335\u20131340. [16] M.I. Alkhalaf, R.H. Hussein, A. Hamza, Green synthesis of silver nanoparticles by Nigella sativa extract alleviates diabetic neuropathy through anti-inflammatory and antioxidant effects, Saudi J. Biol. Sci. 27 (9) (2020) 2410\u20132419. [17] Y. Kabir, Y. Akasaka-Hashimoto, K. Kubota, M. Komai, Volatile compounds of black cumin (Nigella sativa L.) seeds cultivated in Bangladesh and India, Heliyon 6 (10) (2020), e05343. [18] K. Leisegang, W. Almaghrawi, R. Henkel, The effect of Nigella sativa oil and metformin on male seminal parameters and testosterone in Wistar rats exposed to an obesogenic diet, Biomed. Pharm. 133 (2021), 111085. [19] M. Esmail, S. Anwar, M. Kandeil, A.M. El-Zanaty, M. Abdel-Gabbar, Effect of Nigella sativa, atorvastatin, or L-carnitine on high fat diet-induced obesity in adult male Albino rats, Biomed. Pharm. 141 (2021), 111818. [20] S.N. Goyal, C.P. Prajapati, P.R. Gore, C.R. Patil, U.B. Mahajan, C. Sharma, S. P. Talla, S.K. Ojha, Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin, Front Pharmacol. 8 (2017) 656. [21] K. Chaieb, B. Kouidhi, H. Jrah, K. Mahdouani, A. Bakhrouf, Antibacterial activity of thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation, BMC Complement. Alter. Med. 11 (1) (2011) 29. [22] S. Goel, P. Mishra, Thymoquinone inhibits biofilm formation and has selective antibacterial activity due to ROS generation, Appl. Microbiol. Biotechnol. 102 (4) (2018) 1955\u20131967. [23] A. Mouwakeh, A. Telbisz, G. Spengler, C. Mohacsi-Farkas, G. Kisko, Antibacterial and resistance modifying activities of nigella sativa essential oil and its active compounds against listeria monocytogenes, Vivo 32 (4) (2018) 737\u2013743. [24] S. Maiti, A. Banerjee, A. Nazmeen, M. Kanwar, S. Das, Active-site molecular docking of Nigellidine to nucleocapsid/Nsp2/Nsp3/MPro of COVID-19 and to human IL1R and TNFR1/2 may stop viral-growth/cytokine-flood, and the drug source Nigella sativa (black cumin) seeds show potent antioxidant role in experimental rats, Res. Sq. (2020). [25] R. Jakhmola Mani, N. Sehgal, N. Dogra, S. Saxena, D. Pande Katare, , Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: in-silico study, J. Biomol. Struct. Dyn. (2020) 1\u201313. [26] A.R. Khosravi, H. Shokri, M. Minooeianhaghighi, Inhibition of aflatoxin production and growth of Aspergillus parasiticus by cuminum cyminum, Ziziphora clinopodioides, and Nigella sativa essential oils, Foodborne Pathog. Dis. 8 (12) (2011) 1275\u20131280. [27] H. Almshawit, I. Macreadie, Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata, Microbiol. Res. 195 (2017) 81\u201388. [28] S.H.M. Aljabre, O.M. Alakloby, M.A. Randhawa, Dermatological effects of Nigella sativa, J. Dermatol. Dermatol. Surg. 19 (2) (2015) 92\u201398. [29] S.K. Ahmed, I.G. Mohammed, E.O. El badri, M.D. Mahmoud, S.K. Waleed, A. Nadir, In vitro antimicrobial activity of ethanolic seeds extract of Nigella sativa (Linn) in Sudan, African, J. Microbiol. Res. 9 (11) (2015) 788\u2013792. [30] B.E.M. Alahmad, N.F. Mohamed Yusoff, N.S. Mustafa, P.K. Subramaniam, D. S. Darnis, K.I. Mokhtar, Potential antibacterial effects of flaxseed and Nigella sativa extracts on Streptococcus pyogenes, IIUM J. Orofac. Health Sci. 1 (1) (2020) 11\u201316. [31] B.H. Ali, G. Blunden, Pharmacological and toxicological properties of Nigella sativa, Phytother. Res. PTR 17 (4) (2003) 299\u2013305. [32] E. Elariny, A. Amer, Y. El-senosy, S. Naaom, Antimicrobial activity of Nigella sativa and Lawsonia inermis (Henna) against Gram negative bacteria isolated from clinical samples, IOSR J. Biotechnol. Biochem. 6 (3) (2020) 32\u201337. [33] E. Halawani, Antibacterial activity of thymoquinone and thymohydroquinone of Nigella sativa L. and their interaction with some antibiotics, Adv. Biol. Res. 3 (5\u20136) (2009) 148\u2013152. [34] P.C.M. Jansen, Spices, Condiments and Medicinal Plants in Ethiopia, Their Taxonomy and Agricultural Significance, Backhuys Publishers, Wageningen, 1981. [35] A.P. Sommer, H.D. Forsterling, K.E. Sommer, Tutankhamun\u2019s Antimalarial Drug for Covid-19, Drug Res. 71 (1) (2021) 4\u20139. [36] S.K. Malhotra, Nigella, in: K.V. Peter (Ed.), Handbook of Herbs and Spices, Woodhead Publishing, 2012, pp. 391\u2013416. [37] K. Srinivasan, Cumin (Cuminum cyminum) and black cumin (Nigella sativa) seeds: traditional uses, chemical constituents, and nutraceutical effects, Food Qual. Saf. Oxf. 2 (1) (2018) 1\u201316. [38] P.M. Paarakh, Nigella sativa Linn.\u2013a comprehensive review, Indian J. Nat. Prod. Resour. 1 (4) (2010) 409\u2013429. [39] ITIS, Nigella sativa L., 2021. www.itis.gov. https://doi.org/10.5066/F7KH0KBK. (Accessed 12 June 2021). [40] M.F. Ramadan, Black Cumin (Nigella sativa) Seeds: Chemistry, Technology, Functionality, and Applications, Springer, Cham, Switzerland, 2021. [41] A.M. Bendre, A. Kumar, A Text Book Of Practical Botany 2, Rastogi Publications, Meerut-250002, India, 2009. [42] J. Otieno, S. Abihudi, S. Veldman, M. Nahashon, T. van Andel, H.J. de Boer, Vernacular dominance in folk taxonomy: a case study of ethnospecies in medicinal plant trade in Tanzania, J. Ethnobiol. Ethnomed. 11 (1) (2015) 10. [43] M.K. Sahak, N. Kabir, G. Abbas, S. Draman, N.H. Hashim, D.S. Hasan Adli, The Role of Nigella sativa and its active constituents in learning and memory, Evid. Based Complement. Altern. Med. 2016 (2016), 6075679. [44] A. Mannan, S. Begum, A review on nigella sativa: a marvel herb, J. Drug Deliv. Ther. 10 (2) (2020) 213\u2013219. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 23 [45] A.K. Datta, A. Saha, A. Bhattacharya, A. Mandal, R. Paul, S. Sengupta, Black cumin (Nigella sativa L.)\u2013a review, J. Plant Dev. Sci. 4 (1) (2012) 1\u201343. [46] H. Melnyk, L. Stalyus, T. Kozak, The perspectives of Nigella sativa L. growing in the climatic conditions of the precarpathian region, Pharma Innov. 4 (3, Part A) (2015) 24. [47] K. Giridhar, G. Reddy, S. Surya Kumari, L. Naram Naidu, Nigella: A Seed Spice of Blessing, Spice India, 2015. [48] H. Rouhi, A. Sepehri, F. Karimi, Study of dormancy-breaking of Black cumin seeds (Nigella sativa L.), annals of biological research 3 (6) (2012) 2651\u20132655. [49] J.A. Duke, Ecosystematic data on medicinal plants, Cultiv. Util. Med. Plants (1982) 13\u201323. [50] A. Bibi, M.A. Khan, M. Adil, Z.U.R. Mashwani, Production of callus biomass and antioxidant secondary metabolites in black cumin, J. Anim. Plant Sci. 28 (5) (2018) 1321\u20131328. [51] S.I. Bhuyan, M.S. Hossain, M.M. Islam, S.N. Begum, Z. Urbi, M.S. Hossain, Molecular assessment of genetic diversity and relationship in selected mungbean germplasms, Biotechnology 13 (3) (2014) 126\u2013134. [52] M.S. Hossain, Z. Urbi, I.C. Phang, Auxin increased adventitious root development in the medicinal plant Andrographis paniculata (Burm. f.) Wall. ex Nees, Agron. J. 113 (4) (2021) 3222\u20133231. [53] M.S. Hossain, Z. Urbi, Effect of naphthalene acetic acid on the adventitious rooting in shoot cuttings of andrographis paniculata(Burm.f.) Wall. ex nees: an important therapeutical herb, Int. J. Agron. 2016 (2016) 1\u20136. [54] M.S. Hossain, The effect of salinity stress on the morpho-physiology and protein profile of andrographis paniculata, department of biotechnology, kulliyyah of science, International Islamic University Malaysia, Kuantan, Pahang, Malaysia (2016) 9. [55] M.S. Hossain, Present scenario of global salt affected soils, its management and importance of salinity research, Int Res J Biol Sci 1(1) (2019) 1\u20133. [56] M.S. Hossain, Proteomic Studies, Contribution to understanding plant salinity stress response, Glob. J. Bot. Sci. 8 (2020) 1\u201310. [57] D. Talei, A. Valdiani, M. Maziah, S.R. Sagineedu, M.S. Saad, Analysis of the anticancer phytochemicals in Andrographis paniculata Nees. under salinity stress, Biomed. Res. Int. 2013 (2013), 319047. [58] R. Verpoorte, R. van der Heijden, H.J.G. ten Hoopen, J. Memelink, Metabolic engineering of plant secondary metabolite pathways for the production of fine chemicals, Biotechnol. Lett. 21 (6) (1999) 467\u2013479. [59] M.S. Hossain, Role of Proteomics Analysis in Revealing the Molecular Mechanisms of Altered Physiological Traits of Plant under Salinity Stress, in: Murtaza Abid, M. M. Abid Ali Khan, Amber Hasan, Ratna Katiyar (Eds.), Plant Proteomics: Concept and Applications, Discovery Publishing House Pvt. Ltd., New Delhi, India, 2021, pp. 132\u2013151. [60] R. Nikolic\u0301, N. Mitic\u0301, R. Miletic\u0301, M. Nes\u030ckovic\u0301, Effects of cytokinins on in vitro seed germination and early seedling morphogenesis in lotus corniculatus L, J. Plant Growth Regul. 25 (3) (2006) 187\u2013194. [61] I. Botnick, W. Xue, E. Bar, M. Ibdah, A. Schwartz, D.M. Joel, E. Lev, A. Fait, E. Lewinsohn, Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses, Molecules 17 (9) (2012) 10159\u201310177. [62] N. Sharma, D. Ahirwar, D. Jhade, S. Gupta, Medicinal and phamacological potential of Nigella sativa: a review, Ethnobot. Leafl. 2009 (7) (2009). [63] M.F. Ramadan, Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): an overview, Int. J. Food Sci. Technol. 42 (10) (2007) 1208\u20131218. [64] A.-uh. Gilani, Q. Jabeen, M.A.U. Khan, A review of medicinal uses and pharmacological activities of Nigella sativa, Pak. J. Biol. Sci. 7 (4) (2004) 441\u2013451. [65] M.S. Hossain, Z. Urbi, F.Z. Evamoni, F.T. Zohora, K.M.H. Rahman, A secondary research on medicinal plants mentioned in the Holy Qur\u2019an, J. Med. Plants 3 (59) (2016) 81\u201397. [66] Z. Urbi, M.S. Hossain, K.M.H. Rahman, T.M. Zayed, Grape: a medicinal fruit species in the holy Qur\u2019an and its ethnomedicinal importance, World Appl. Sci. J. 30 (3) (2014) 253\u2013265. [67] L.J. Musselman, Holy Pharmacy - Medicine from Plants of the Bible and Qu\u2019ran Holy Pharmacy Modern Medical Uses of Some Plants of the Qu\u2019ran and the Bible 2000 , https://ww2.odu.edu/~lmusselm/plant/bible/holypharmacy.php. (Accessed 12 December 2020. [68] M. Tariq, Nigella sativa seeds: folklore treatment in modern day medicine, Saudi J. Gastroenterol. 14 (3) (2008) 105\u2013106. [69] E.M. Yimer, K.B. Tuem, A. Karim, N. Ur-Rehman, F. Anwar, Nigella sativa L. (Black Cumin): a promising natural remedy for wide range of illnesses, Evid. Based Complement. Altern. Med. 2019 (2019), 1528635. [70] A. Shabana, A. El-Menyar, M. Asim, H. Al-Azzeh, H. Al, Thani, cardiovascular benefits of black cumin (Nigella sativa), Cardiovasc. Toxicol. 13 (1) (2013) 9\u201321. [71] S.A. Ali, N. Parveen, A.S. Ali, Links between the Prophet Muhammad (PBUH) recommended foods and disease management: a review in the light of modern superfoods, Int. J. Health Sci. 12 (2) (2018) 61\u201369. [72] S.A. Khan, K. Al-Balushi, Combating COVID-19: the role of drug repurposing and medicinal plants, J. Infect. Public Health 14 (4) (2021) 495\u2013503. [73] A.P. Sommer, H.D. Forsterling, K.E. Sommer, Thymoquinone: shield and sword against SARS-CoV-2, Precis Nanomed. 3 (3) (2020) 541\u2013548. [74] A.O. Bamosa, H. Kaatabi, F.M. Lebdaa, A.M. Elq, A. Al-Sultanb, Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus, Indian J. Physiol. Pharmacol. 54 (4) (2010) 344\u2013354. [75] M.S. Bin Sayeed, M. Asaduzzaman, H. Morshed, M.M. Hossain, M.F. Kadir, M. R. Rahman, The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers, J. Ethnopharmacol. 148 (3) (2013) 780\u2013786. [76] U. Kalus, A. Pruss, J. Bystron, M. Jurecka, A. Smekalova, J.J. Lichius, H. Kiesewetter, Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases, Phytother. Res. PTR 17 (10) (2003) 1209\u20131214. [77] S.S. Azimova, A.I. Glushenkova, V.I. Vinogradova. Lipids, lipophilic components and essential oils from plant sources, Springer-Verlag, London, London, 2012. [78] R. Tisserand, R. Young. Essential Oil Safety: A Guide for Health Care Professionals, 2nd ed., Churchill Livingstone, London, United Kingdom, 2013. [79] S. Cheikh-Rouhou, S. Besbes, B. Hentati, C. Blecker, C. Deroanne, H. Attia, Nigella sativa L.: Chemical composition and physicochemical characteristics of lipid fraction, Food Chem 101 (2) (2007) 673\u2013681. [80] H. Lutterodt, M. Luther, M. Slavin, J.-J. Yin, J. Parry, J.-M. Gao, L. Yu, Fatty acid profile, thymoquinone content, oxidative stability, and antioxidant properties of cold-pressed black cumin seed oils, LWT - Food Science and Technology 43 (9) (2010) 1409\u20131413. [81] B.L. Sampaio, R. Edrada-Ebel, F.B. Da Costa, Effect of the environment on the secondary metabolic profile of Tithonia diversifolia: a model for environmental metabolomics of plants, Sci. Rep. 6 (2016) 29265. [82] A. Kessler, A. Kalske, Plant secondary metabolite diversity and species interactions, Annu. Rev. Ecol. Evol. Syst. 49 (1) (2018) 115\u2013138. [83] M.S. Hossain, Z. Urbi, A. Sule, K.M. Hafizur Rahman, Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology, Scientific World J. 2014 (2014), 274905. [84] A. Adamska, J. Stefanowicz-Hajduk, J.R. Ochocka, Alpha-hederin, the active saponin of nigella sativa, as an anticancer agent inducing apoptosis in the SKOV-3 cell line, Molecules 24 (16) (2019). [85] S. Rooney, M.F. Ryan, Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines, Anticancer Res. 25 (3B) (2005) 2199\u20132204. [86] S.S. Kumara, B.T. Huat, Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa, Planta Med. 67 (1) (2001) 29\u201332. [87] R. Keyhanmanesh, S. Saadat, M. Mohammadi, A.A. Shahbazfar, M. Fallahi, The protective effect of alpha-hederin, the active constituent of Nigella sativa, on lung inflammation and blood cytokines in ovalbumin sensitized guinea pigs, Phytother. Res. PTR 29 (11) (2015) 1761\u20131767. [88] Y.A. Mahmmoud, S.B. Christensen, Oleic and linoleic acids are active principles in Nigella sativa and stabilize an E(2)P conformation of the Na,K-ATPase. Fatty acids differentially regulate cardiac glycoside interaction with the pump, Biochim. Biophys. Acta 1808 (10) (2011) 2413\u20132420. [89] S. Maiti, A. Banerjee, A. Nazmeen, M. Kanwar, S. Das, Active-site molecular docking of Nigellidine to nucleocapsid/Nsp2/Nsp3/MPro of COVID-19 and to human IL1R and TNFR1/2 may stop viral-growth/cytokine-flood, and the drug source Nigella sativa (black cumin) seeds show potent antioxidant role in experimental rats, Res. Sq. (2020). [90] E.G. Ndirangu, S. Opiyo, M.W. Ng\u2019ang\u2019a, Chemical composition and repellency of Nigella sativa L. seed essential oil against Anopheles gambiae sensu stricto, Trends in Phytochemical, Research 4 (2) (2020) 77\u201384. [91] R. Atta ur, S. Malik, S.S. Hasan, M.I. Choudhary, C.-Z. Ni, J. Clardy, Nigellidine \u2014 A new indazole alkaloid from the seeds of Nigella sativa, Tetrahedron Letters 36 (12) (1995) 1993\u20131996. [92] Z. Ali, D. Ferreira, P. Carvalho, M.A. Avery, I.A. Khan, Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa, J Nat Prod 71 (6) (2008) 1111\u20131112. [93] R. Atta ur, S. Malik, H. Cun-heng, J. Clardy, Isolation and structure determination of nigellicine, a novel alkaloid from the seeds of, Tetrahedron Letters 26 (23) (1985) 2759\u20132762. [94] R. Atta ur, S. Malik, K.Nigellimine Zaman, A New Isoquinoline Alkaloid from the Seeds of Nigella sativa, Journal of Natural Products 55 (5) (2004) 676\u2013678. [95] T. Morikawa, F. Xu, Y. Kashima, H. Matsuda, K. Ninomiya, M. Yoshikawa, Novel dolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the seeds of Nigella sativa, Org Lett 6 (6) (2004) 869\u2013872. [96] T. Morikawa, F. Xu, K. Ninomiya, H. Matsuda, M. Yoshikawa, Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism- promoting activities from the Egyptian medicinal food black cumin, Chem Pharm Bull (Tokyo) 52 (4) (2004) 494\u2013497. [97] B.K. Mehta, M. Verma, M. Gupta, Novel lipid constituents identified in seeds of Nigella sativa (Linn), Journal of the Brazilian Chemical Society 19 (3) (2008) 458\u2013462. [98] B. Nickavar, F. Mojab, K. Javidnia, M.A. Amoli, Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran, Z Naturforsch C J Biosci 58 (9\u201310) (2003) 629\u2013631. [99] F. Benkaci\u2013Ali, A. Baaliouamer, B.Y. Meklati, F. Chemat, Chemical composition of seed essential oils from AlgerianNigella sativa extracted by microwave and hydrodistillation, Flavour and Fragrance, Journal 22 (2) (2007) 148\u2013153. [100] S. Bourgou, R. Ksouri, A. Bellila, I. Skandrani, H. Falleh, B. Marzouk, Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots, C R Biol 331 (1) (2008) 48\u201355. [101] A. Topcagic, S. Cavar Zeljkovic, E. Karalija, S. Galijasevic, E. Sofic, Evaluation of phenolic profile, enzyme inhibitory and antimicrobial activities of Nigella sativa L. seed extracts, Bosn J Basic Med Sci 17 (4) (2017) 286\u2013294. [102] S. Cheikh-Rouhou, S. Besbes, G. Lognay, C. Blecker, C. Deroanne, H. Attia, Sterol composition of black cumin (Nigella sativa L.) and Aleppo pine (Pinus halepensis Mill.) seed oils, Journal of Food Composition and Analysis 21 (2) (2008) 162\u2013168. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 24 [103] S.J. Gerige, M.K.Y. Gerige, M. Rao, Ramanjaneyulu, GC-MS analysis of Nigella sativa seeds and antimicrobial activity of its volatile oil, Brazilian Archives of Biology and Technology 52 (5) (2009) 1189\u20131192. [104] S.K.T. Venkatachallam, H. Pattekhan, S. Divakar, U.S. Kadimi, Chemical composition of Nigella sativa L. seed extracts obtained by supercritical carbon dioxide, J Food Sci Technol 47 (6) (2010) 598\u2013605. [105] S.S. Muthu Kumara, B.T.K. Huat, Extraction, Isolation and Characterisation of Antitumor Principle, \u03b1-Hederin, from the Seeds of Nigella sativa, Planta Med 67 (01) (2001) 29\u201332. [106] L. Kokoska, J. Havlik, I. Valterova, H. Sovova, M. Sajfrtova, I. Jankovska, Comparison of chemical composition and antibacterial activity of Nigella sativa seed essential oils obtained by different extraction methods, J Food Prot 71 (12) (2008) 2475\u20132480. [107] E. Halawani, Antibacterial activity of thymoquinone and thymohydroquinone of Nigella sativa L. and their interaction with some antibiotics, Advances in Biological Research 3 (5\u20136) (2009) 148\u2013152. [108] H. Mahmoudvand, A. Sepahvand, S. Jahanbakhsh, B. Ezatpour, S.A. Ayatollahi Mousavi, Evaluation of antifungal activities of the essential oil and various extracts of Nigella sativa and its main component, thymoquinone against pathogenic dermatophyte strains, J Mycol Med 24 (4) (2014) e155\u201361. [109] H. Almshawit, I. Macreadie, Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata, Microbiol Res 195 (2017) 81\u201388. [110] M. Taha, A. Azeiz, W. Saudi, Antifungal effect of thymol, thymoquinone and thymohydroquinone against yeasts, dermatophytes and non-dermatophyte molds isolated from skin and nails fungal infections, Egyptian Journal of Biochemistry & Molecular Biology 28 (2) (2010) 109\u2013126. [111] A. Mouwakeh, A. Telbisz, G. Spengler, C. Mohacsi-Farkas, G. Kisko, Antibacterial and Resistance Modifying Activities of Nigella sativa Essential Oil and its Active Compounds Against Listeria monocytogenes, In, Vivo 32 (4) (2018) 737\u2013743. [112] A. Mutabagani, S.A. El-Mahdy, A study of the anti-inflammatory activity of Nigella sativa L. and thymoquinone in rats, Saudi Pharmaceutical Journal 5 (2) (1997) 110\u2013113. [113] P. Marsik, L. Kokoska, P. Landa, A. Nepovim, P. Soudek, T. Vanek, In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses, Planta Med 71 (8) (2005) 739\u2013742. [114] C.C. Woo, S.Y. Loo, V. Gee, C.W. Yap, G. Sethi, A.P. Kumar, K.H. Tan, Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR- gamma pathway, Biochem Pharmacol 82 (5) (2011) 464\u2013475. [115] H. Hosseinzadeh, S. Parvardeh, Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice, Phytomedicine 11 (1) (2004) 56\u201364. [116] H. Mahmoudvand, R. Tavakoli, F. Sharififar, K. Minaie, B. Ezatpour, S. Jahanbakhsh, I. Sharifi, Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone, Pharm Biol 53 (7) (2015) 1052\u20131057. [117] A.S. Butt, N. Nisar, N. Ghani, I. Altaf, T.A. Mughal, Isolation of thymoquinone from Nigella sativa L. and Thymus vulgaris L., and its anti-proliferative effect on HeLa cancer cell lines, Trop. J. Pharm. Res. 18 (1) (2019) 37\u201342. [118] N. Chehl, G. Chipitsyna, Q. Gong, C.J. Yeo, H.A. Arafat, Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells, HPB (Oxford) 11 (5) (2009) 373\u2013381. [119] H. Gali-Muhtasib, M. Diab-Assaf, C. Boltze, J. Al-Hmaira, R. Hartig, A. Roessner, R. Schneider-Stock, Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism, Int J Oncol 25 (4) (2004) 857\u2013866. [120] S. Dinagaran, S. Sridhar, P. Eganathan, Chemical Composition and Antioxidant Activities of Black Seed Oil (Nigella Sativa L.), Int J Pharm Sci Res 7 (11) (2016) 4473\u20134479. [121] A.M. Abdel-Fattah, K. Matsumoto, H. Watanabe, Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice, Eur J Pharmacol 400 (1) (2000) 89\u201397. [122] H.J. Harzallah, B. Kouidhi, G. Flamini, A. Bakhrouf, T. Mahjoub, Chemical composition, antimicrobial potential against cariogenic bacteria and cytotoxic activity of Tunisian Nigella sativa essential oil and thymoquinone, Food Chem 129 (4) (2011) 1469\u20131474. [123] A.J. Walker, D.R. Bassett Jr., W.J. Duey, E.T. Howley, V. Bond, D.J. Torok, P. Mancuso, Cardiovascular and plasma catecholamine responses to exercise in blacks and whites, Hypertension 20 (4) (1992) 542\u2013548. [124] T. Morikawa, F. Xu, Y. Kashima, H. Matsuda, K. Ninomiya, M. Yoshikawa, Novel dolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the seeds of Nigella sativa, Org. Lett. 6 (6) (2004) 869\u2013882. [125] T. Morikawa, F. Xu, K. Ninomiya, H. Matsuda, M. Yoshikawa, Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism- promoting activities from the Egyptian medicinal food black cumin, Chem. Pharm. Bull. 52 (4) (2004) 494\u2013497. [126] Y. Niu, L. Zhou, L. Meng, S. Chen, C. Ma, Z. Liu, W. Kang, Recent progress on chemical constituents and pharmacological effects of the Genus Nigella, Evid. Based Complement Altern. Med. 2020 (2020), 6756835. [127] V.K. Babayan, D. Koottungal, G.A. Halaby, Proximate analysis, fatty acid and amino acid composition of Nigella sativa L. seeds, J. Food Sci. 43 (4) (1978) 1314\u20131315. [128] A. Topcagic, S. Cavar Zeljkovic, E. Karalija, S. Galijasevic, E. Sofic, Evaluation of phenolic profile, enzyme inhibitory and antimicrobial activities of Nigella sativa L. seed extracts, Bosn. J. Basic Med. Sci. 17 (4) (2017) 286\u2013294. [129] S. Bourgou, R. Ksouri, A. Bellila, I. Skandrani, H. Falleh, B. Marzouk, Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots, C. R. Biol. 331 (1) (2008) 48\u201355. [130] M.M.O\u0308. Bertrand, Matthaus fatty acids, tocopherol, and sterol contents of some nigella species seed oil, Czech J. Food Sci. 29 (2) (2011) 145\u2013150. [131] M. Arici, O. Sagdic, U. Gecgel, Antibacterial effect of Turkish black cumin (Nigella sativa L.) oils, Grasas Aceites 56 (4) (2007) 259\u2013262. [132] A.R. Khan, K. Kour, Wide spectrum antibacterial activity of Nigella sativa L. seeds, IOSR J. Pharm. 7 (6) (2016) 12\u201316. [133] A. Hannan, S. Saleem, S. Chaudhary, M. Barkaat, M.U. Arshad, Anti bacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus, J. Ayub Med. Coll. Abbottabad 20 (3) (2008) 72\u201374. [134] N.A. Mohammed, Effect of Nigella sativa L. extracts against Streptococcus mutans and Streptococcus mitis in Vitro, J. Baghdad Coll. Dent. 24 (3) (2012) 154\u2013157. [135] S. Ashraf, A.A. Anjum, A. Ahmad, S. Firyal, S. Sana, A.A. Latif, In vitro activity of Nigella sativa against antibiotic resistant Salmonella enterica, Environ. Toxicol. Pharmacol. 58 (2018) 54\u201358. [136] H. Zuridah, A. Fairuz, A. Zakri, M. Rahim, In vitroantibacterial activity of Nigella sativa against Staphylococcus aureus,Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli and Bacilluscereus, Asian J. Plant Sci. 7 (3) (2008) 331\u2013333. [137] M.M. Alam, M. Yasmin, J. Nessa, C.R. Ahsan, Antibacterial activity of chloroform and ethanolextracts of black cumin seeds (Nigella sativa) against multi-drug resistanthuman pathogens under laboratory conditions, J. Med. Plants Res. 4 (18) (2010) 1901\u20131905. [138] M. Besra, V. Kumar, In vitro investigation ofantimicrobial activities of ethnomedicinal plants against dental cariespathogens, 3 Biotech 8(5) (2018) 257. [139] N.W. Nawarathne, K. Wijesekera, W. Wijayaratne, M. Napagoda, Development of Novel Topical Cosmeceutical Formulationsfrom Nigella sativa L. with Antimicrobial Activity against Acne-Causing Microorganisms, Scientific World Journal 2019 (2019), 5985207. [140] T. Mosolygo, A. Mouwakeh, M. Hussein Ali, A. Kincses, C. Mohacsi-Farkas, G. Kisko, G. Spengler, Bioactive Compounds of Nigella Sativa Essential Oil asAntibacterial Agents against Chlamydia Trachomatis D, Microorganisms 7 (9) (2019) 370. [141] M.S. Hanafy, M.E. Hatem, Studies on the antimicrobial activity of Nigella sativaseed (black cumin), J. Ethnopharmacol 34 (2-3) (1991) 275\u2013278. [142] H. Hosseinzadeh, M.M. Haghi, Antibacterial activity of total extracts and essentialoil of Nigella sativa L. seeds in mice, Pharmacologyonline 2 (2007) 429\u2013435. [143] A.U. Khan, S. Ali, Antibacterial Activity of Nigella sativa and Piper nigrum, Asian Journal of Natural and Applied Sciences 2 (4) (2013) 173\u2013179. [144] M. Rahman, M. Wadud, T. Islam, M. Hussain, E. Bristy, A. Tuhin, Evaluation of Antibacterial Activity of Piper betel Leaves and Nigella sativa Seeds against Multidrug Resistant Food and Water Borne Pathogenic Bacteria: An in vitro Study Model, Microbiology Research Journal International 22 (4) (2018) 1\u201311. [145] M.A. Randhawa,, A.K. Alenazy, M.G. Alrowaili, J. Basha, An active principle of Nigella sativa L., thymoquinone, showing significant antimicrobial activity against anaerobic bacteria, J. Intercult. Ethnopharmacol. 6 (1) (2017) 97\u2013101. [146] P. Ilango, K. Senthilnathan, T. Abirami, V. Vummidi, A. Mahalingam, V. Reddy, Evaluation of antibacterial activity of Nigella sativa seed extract against Porphyromonas gingivalis and Prevotella intermedia, Journal of Interdisciplinary Dentistry 10 (2) (2020) 51\u201355. [147] N.A. Hasan, M.Z. Nawahwi, H. Ab Malek, Antimicrobial Activity of Nigella sativa Seed Extract, Sains Malays 42 (2) (2013) 143\u2013147. [148] CDC, Antibiotic Resistance Threats in the United States, 2019, p. 2019. www.cdc. gov/DrugResistance/Biggest-Threats.html. [149] Y. Habboush, M.D. Benham, T. Louie, A. Noor, R.M. Sprague, New York State Infection Control, StatPearls, StatPearls Publishing, Treasure Island (FL), 2021. [150] F. Van Bambeke, J.M. Pages, V.J. Lee, Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux, Recent Pat. Antiinfect Drug Disco 1 (2) (2006) 157\u2013175. [151] J.E. Kristiansen, V.F. Thomsen, A. Martins, M. Viveiros, L. Amaral, Non- antibiotics reverse resistance of bacteria to antibiotics, Vivo 24 (5) (2010) 751\u2013754. [152] N.A. Romanova, P.F. Wolffs, L.Y. Brovko, M.W. Griffiths, Role of efflux pumps in adaptation and resistance of Listeria monocytogenes to benzalkonium chloride, Appl. Environ. Microbiol. 72 (5) (2006) 3498\u20133503. [153] M.T. Mata, F. Baquero, J.C. Perez-Diaz, A multidrug efflux transporter in Listeria monocytogenes, FEMS Microbiol. Lett. 187 (2) (2000) 185\u2013188. [154] S. Godreuil, M. Galimand, G. Gerbaud, C. Jacquet, P. Courvalin, Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes, Antimicrob. Agents Chemother. 47 (2) (2003) 704\u2013708. [155] S. Umar, M.T. Munir, S. Subhan, T. Azam, Q. un Nisa, M.I. Khan, W. Umar, Z. ur Rehman, A.S. Saqib, M.A. Shah, Withdrawn: Protective and antiviral activities of Nigella sativa against avian influenza (H9N2) in Turkeys, J. Saudi Soc. Agric. Sci. (2016). [156] A.A. Onifade, A.P. Jewell, W.A. Adedeji, Nigella sativa concoction induced sustained seroreversion in HIV patient, Afr. J. Tradit. Complement. Alter. Med. 10 (5) (2013) 332\u2013335. [157] M.L. Salem, M.S. Hossain, Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection, Int. J. Immunopharmacol. 22 (9) (2000) 729\u2013740. [158] A.U. Khan, In-ovo antiviral effect of Nigella sativa extract against newcastle disease virus in experimentally infected chicken embryonated eggs, Pak. Vet. J. 38 (04) (2018) 434\u2013437. Md.S. Hossain et al. Biomedicine & Pharmacotherapy 143 (2021) 112182 25 [159] S. Ahmad, H.W. Abbasi, S. Shahid, S. Gul, S.W. Abbasi, Molecular docking, simulation and MM-PBSA studies of Nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment, J. Biomol. Struct. Dyn. 39 (12) (2021) 4225\u20134233. [160] Y.H. Mohammed, J.M. Ghaidaa, H.H. Imad, Analysis of bioactive chemical compounds of Nigella sativa using gas chromatography-mass spectrometry, J. Pharmacogn. Phytother. 8 (2) (2016) 8\u201324. [161] M.T. Rahman, Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19, J. Herb. Med. 23 (2020), 100382. [162] S. Bouchentouf, N. Missoum, Identification of compounds from Nigella sativa as new potential inhibitors of 2019 novel coronasvirus (Covid-19): molecular docking study, Preprints (2020). [163] S. Ashraf, S. Ashraf, M. Ashraf, M.A. Imran, L. Kalsoom, U.N. Siddiqui, I. Farooq, Z. Habib, S. Ashraf, M. Ghufran, M.K. Akram, N. Majeed, A. Zain ul, R. Akmal, S. Rafique, K. Nawaz, M.I.K. Yousaf, S. Ahmad, M.S. Shahab, M.F. Nadeem, M. Azam, H. Zheng, A. Malik, M. Ayyaz, T. Mahmud, Q.A. Saboor, A. Ahmad, M. Ashraf, M. Izhar, A. Hilal, A. Muhammad, Z. Shaukat, A. Khaqan, K. Hayat, S. Arshad, M. Hassan, A. Abeer bin, A. Ahmad, T. Mughal, A.R. Virk, M. Umer, M. Suhail, S. Zulfiqar, S. Sarfraz, M.I. Anwar, A. Humayun, R.A. Khokhar, S. Siddique, Therapeutic efficacy of Honey and Nigella sativa against COVID-19: a multi-center randomized controlled clinical trial (HNS-COVID-PK), medRxiv (2020). [164] S.M.E. Sayed, H.H. Almaramhy, Y.T. Aljehani, A.M. Okashah, M.E. El-Anzi, M. B. AlHarbi, R. El-Tahlawi, M.M.H. Nabo, M.S. Aboonq, O. Hamouda, O. Alhadramy, The evidence-based TaibUVID nutritional treatment for minimizing COVID-19 fatalities and morbidity and eradicating COVID-19 pandemic: a novel approach for better outcomes (a treatment protocol), Am. J. Public Health Res. 8 (2) (2020) 54\u201360. [165] A. Asdadi, H. Harhar, S. Gharby, Z. Bouzoubaa\u0302, Chemical composition and antifungal activity of Nigella sativa L. oil seed cultivated in Morocco, Int. J. Pharm. Sci. Invent. 3 (11) (2014) 09\u201315. [166] M.N.S.S. Gupta, B. Duraiswamy, S. Das, M. Chhajed, Potential herbs and its phytoconstituents against fungal infection: a systematic review, World J. Pharm. Res. 1 (1) (2012) 01\u201320. [167] M.A. Khan, M.K. Ashfaq, H.S. Zuberi, M.S. Mahmood, A.H. Gilani, The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds, Phytother. Res. PTR 17 (2) (2003) 183\u2013186. [168] I.M. Fierro, C. Barja-Fidalgo, F.Q. Cunha, S.H. Ferreira, The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils, Immunology 89 (2) (1996) 295\u2013300. [169] H. Shokri, A review on the inhibitory potential of Nigella sativa against pathogenic and toxigenic fungi, Avicenna J. Phytomed. 6 (1) (2016) 21\u201333. [170] N.H. Nadaf, S.S. Gawade, A.S. Muniv, S.R. Waghmare, D.B. Jadhav, K. D. Sonawane, Exploring anti-yeast activity of Nigella sativa seed extracts, Ind. Crop Prod. 77 (2015) 624\u2013630. [171] A. Naeini, A.R. Khosravi, M. Chitsaz, H. Shokri, M. Kamlnejad, Anti- Candida albicans activity of some Iranian plants used in traditional medicine, Journal de Mycologie Me\u0301dicale 19 (3) (2009) 168\u2013172. [172] A.R. Khosravi, H. Shokri, Z. Farahnejat, R. Chalangari, M. Katalin, Antimycotic efficacy of Iranian medicinal plants towards dermatophytes obtained from patients with dermatophytosis, Chin J Nat Medicines 11 (1) (2013) 43\u201348. [173] S.H. Aljabre, M.A. Randhawa, N. Akhtar, O.M. Alakloby, A.M. Alqurashi, A. Aldossary, Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone, J Ethnopharmacol 101 (1\u20133) (2005) 116\u2013119. [174] A.R. Khosravi, M.H. Minooeianhaghighi, H. Shokri, S.A. Emami, S.M. Alavi, J. Asili, The potential inhibitory effect of cuminum cyminum, ziziphora clinopodioides and nigella sativa essential oils on the growth of Aspergillus fumigatus and Aspergillus flavus, Braz J Microbiol 42 (1) (2011) 216\u2013224. [175] H. Mahmoudvand, I. Sharifi, M.F. Harandi, M. Shakibaie, Anti-leishmania effects of methotrexate (MTX) alone and in combination with meglumine antimoniate (MA) against Iranian, Asian Pac. J. Trop. Med. 412 (2014) 420. [176] S.H. Aljabre, M.A. Randhawa, N. Akhtar, O.M. Alakloby, A.M. Alqurashi, A. Aldossary, Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone, J. Ethnopharmacol. 101 (1\u20133) (2005) 116\u2013119. [177] U. Sitara, I. Niaz, J. Naseem, N. Sultana, Antifungal effect of essential oils on In vitro growth of pathogenic fungi, Pak. J. Bot. 40 (1) (2008) 409\u2013414. [178] E.A. Rogozhin, Y.I. Oshchepkova, T.I. Odintsova, N.V. Khadeeva, O. N. Veshkurova, T.A. Egorov, E.V. Grishin, S.I. Salikhov, Novel antifungal defensins from Nigella sativa L. seeds, Plant Physiol. Biochem. 49 (2) (2011) 131\u2013137. [179] A.R. Khosravi, M.H. Minooeianhaghighi, H. Shokri, S.A. Emami, S.M. Alavi, J. Asili, The potential inhibitory effect of Cuminum cyminum, ziziphora clinopodioides and Nigella sativa essential oils on the growth of Aspergillus fumigatus and Aspergillus flavus, Braz. J. Microbiol. 42 (1) (2011) 216\u2013224. [180] M.S. Akhtar, S. Riffat, Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children, J. Pak. Med. Assoc. 41 (8) (1991) 185\u2013187. [181] F. Forouzanfar, B.S. Bazzaz, H. Hosseinzadeh, Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects, Iran. J. Basic Med. Sci. 17 (12) (2014) 929\u2013938. [182] S. V.T, S. F, B. H.M, D. M.S, A review on therapeutic potential of Nigella sativa (kalonji) seeds, J. Med. Plants Res. 8 (3) (2014) 167\u2013177. [183] M.A. Mansour, O.T. Ginawi, T. El-Hadiyah, A.S. El-Khatib, O.A. Al-Shabanah, H. A. Al-Sawaf, Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone, Res. Commun. Mol. Pathol. Pharmacol. 110 (3\u20134) (2001) 239\u2013251. [184] F.Q. Alenzi, S. El-Bolkiny Yel, M.L. Salem, Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide, Br. J. Biomed. Sci. 67 (1) (2010) 20\u201328. [185] A. Zaoui, Y. Cherrah, N. Mahassini, K. Alaoui, H. Amarouch, M. Hassar, Acute and chronic toxicity of Nigella sativa fixed oil, Phytomedicine 9 (1) (2002) 69\u201374. [186] T. Khanna, F. Zaidi, P. Dandiya, CNS and analgesic studies on Nigella sativa, Fitoter. Milano 64 (1993) 407. [187] O.A. Badary, O.A. Al-Shabanah, M.N. Nagi, A.M. Al-Bekairi, M.M.A. Elmazar, Acute and subchronic toxicity of thymoquinone in mice, Drug Dev. Res. 44 (2\u20133) (1998) 56\u201361. [188] N. Vahdati-Mashhadian, H. Rakhshandeh, A. Omidi, An investigation on LD50 and subacute hepatic toxicity of Nigella sativa seed extracts in mice, Pharmazie 60 (7) (2005) 544\u2013547. [189] M.A. Dollah, S. Parhizkar, L.A. Latiff, M.H. Bin Hassan, Toxicity effect of Nigella sativa on the liver function of rats, Adv. Pharm. Bull. 3 (1) (2013) 97\u2013102. [190] O.A. Badary, M.N. Nagi, O.A. al-Shabanah, H.A. al-Sawaf, M.O. al-Sohaibani, A. M. al-Bekairi, Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity, Can. J. Physiol. Pharmacol. 75 (12) (1997) 1356\u20131361. [191] H. Mashayekhi-Sardoo, R. Rezaee, G. Karimi, Nigella sativa (black seed) safety: an overview, Asian Biomed. 14 (4) (2020) 127\u2013137. Md.S. Hossain et al."}